As filed with the Securities and Exchange Commission
on March 3, 2025
Registration
No. 333-
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM S-3
REGISTRATION STATEMENT UNDER THE SECURITIES
ACT OF 1933
CELESTICA INC.
(Exact name of Registrant as specified in its charter)
ONTARIO, CANADA
(State or other jurisdiction of
incorporation or organization) |
98-0185558
(I.R.S. Employer
Identification No.) |
5140 Yonge Street, Suite 1900
Toronto, Ontario
Canada M2N 6L7
(416) 448-5800
(Address, including zip code, and telephone number,
including area code, of registrant's principal
executive offices)
The Corporation Trust Company
Corporation Trust Center
1209 Orange Street
Wilmington,
DE 19801
(302) 658-7581
(Name, address, including zip code, and telephone number, including area code, of agent for service)
Copies to:
|
Ryan J. Dzierniejko, Esq.
Skadden, Arps, Slate, Meagher & Flom LLP
One Manhattan West
New York, New York, United States 10001-8602
(212) 735-3712 |
Matthew Merkley, Esq.
Blake, Cassels & Graydon LLP
199 Bay Street, Suite 4000
Commerce Court West
Toronto, Ontario, Canada M5L 1A9
(416) 863-2400 |
Approximate
date of commencement of proposed sale to the public: From time to time after the effective date of this Registration Statement.
If
the only securities being registered on this Form are being offered pursuant to dividend or interest reinvestment plans, please check
the following box. ¨
If
any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the
Securities Act of 1933, other than securities offered only in connection with dividend or interest reinvestment plans, check the following
box. x
If
this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the
following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.
¨
If
this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities
Act registration statement number of the earlier effective registration statement for the same offering. ¨
If
this Form is a registration statement pursuant to General Instruction I.D. or a post-effective amendment thereto that shall become effective
upon filing with the Commission pursuant to Rule 462(e) under the Securities Act, check the following box. x
If
this Form is a post-effective amendment to a registration statement filed pursuant to General Instruction I.D. filed to register additional
securities or additional classes of securities pursuant to Rule 413(b) under the Securities Act, check the following box. ¨
Indicate by check mark whether the registrant
is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company.
See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company" and "emerging
growth company" in Rule 12b-2 of the Exchange Act.
| Large
accelerated filer x | |
Accelerated filer
☐ |
| Non-accelerated filer ☐ | |
Smaller reporting company ☐ |
| | |
Emerging growth company ☐ |
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ¨
PROSPECTUS
Celestica Inc.
Common Shares
Preferred Shares
Debt Securities
Warrants
We may offer and sell from
time to time, in one or more offerings: common shares, preferred shares, debt securities and/or warrants to purchase common shares, preferred
shares, debt securities or warrants (collectively, the "securities"). This prospectus may also be used by our shareholders to
offer our common shares.
This prospectus describes
some of the general terms that may apply to the securities. Each time we (or any selling shareholder) offer to sell any securities, we
will provide specific terms of such securities and the offering in a supplement to this prospectus and/or a free writing prospectus. We
may not use this prospectus to sell securities unless we also give prospective investors a supplement to this prospectus and/or a free
writing prospectus. The prospectus supplement and/or free writing prospectus may also add, update or change information contained in this
prospectus. You should read this prospectus and the applicable prospectus supplement and/or free writing prospectus carefully before you
invest in our securities. All references in this prospectus to a prospectus supplement include references to a free writing prospectus
if a free writing prospectus is filed to set forth any terms of any securities offering hereunder.
We (or any selling shareholder)
may offer the securities for sale in a number of different ways, including directly to purchasers, through one or more agents, or to or
through underwriters or dealers, or through a combination of these methods, on a delayed or continuous basis. For additional information,
you should refer to the section entitled "Plan of Distribution" in this prospectus. If any agents, underwriters or dealers are
involved in the sale of any of our securities, their names, and any applicable purchase price, fee, commission or discount arrangement
between or among them, will be set forth in the applicable prospectus supplement or other offering materials. Any selling shareholder
will be named in a supplement to this prospectus.
Our common shares are listed
on the New York Stock Exchange and the Toronto Stock Exchange and trade under the symbol "CLS." On February 28, 2025, the last
reported sale price of the common shares on the NYSE was $107.05 per common share.
Investing in our securities
involves risk. See the "Risk Factors" section on page 5 of this prospectus, in any applicable prospectus supplement, and in
any documents we incorporate by reference in this prospectus or any applicable prospectus supplement(s) before investing in our securities.
NEITHER
the Securities and Exchange Commission Nor any state securities commission has approved or disapproved of these securities or determined
if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.
The date of this prospectus is March 3, 2025.
TABLE OF CONTENTS
Page
ABOUT THIS PROSPECTUS
In this prospectus, unless
otherwise noted, "Celestica," the "Company," "we," "us" and "our" refer to Celestica
Inc. and its subsidiaries.
This prospectus is part of
an "automatic shelf" registration statement on Form S-3 that we filed with the Securities and Exchange Commission (the "Commission")
as a "well known seasoned issuer" using the "shelf" registration process. Under this shelf registration process, using
this prospectus, we may offer and sell, from time to time, in one or more offerings, any of the securities described in this prospectus
(and our shareholders may offer and sell our common shares). This prospectus provides a general description of the securities we may offer,
as well as other information you should know before investing in our securities. Each time we or selling shareholders sell securities
under this prospectus, we will provide a prospectus supplement and/or free writing prospectus that contains specific information about
the terms of the offering and of the securities being offered. The prospectus supplement or free writing prospectus may also add, clarify,
update or change information contained in this prospectus, and accordingly, to the extent any statement we make in that prospectus supplement
or free writing prospectus is inconsistent with statements made in this prospectus, the statements made in this prospectus will be deemed
modified or superseded by those made in such prospectus supplement or free writing prospectus. No limit exists on the aggregate amount
of the securities we or selling shareholders may sell pursuant to the registration statement of which this prospectus is a part. You should
read this prospectus, any applicable prospectus supplements or free writing prospectuses, together with additional information described
below under the captions "Where You Can Find More Information" and "Incorporation of Certain Information by Reference"
below, before you decide whether to invest in our securities. All references in this prospectus to a prospectus supplement include
references to a free writing prospectus if a free writing prospectus is filed to set forth any terms of any securities offering hereunder.
You should rely only on
the information we provide or incorporate by reference in this prospectus or any applicable prospectus supplement. We have not authorized
anyone to provide you with different or additional information. You should not assume that the information contained in this prospectus,
any prospectus supplement, or any other document we incorporate by reference herein or therein is accurate as of any date other than the
date of such documents, regardless of the time of delivery of the prospectus, prospectus supplement, or any sale of the securities. Our
business, financial condition, results of operations and prospects, as well as other information, may have changed since such dates.
This prospectus does not contain
all of the information included in the registration statement of which it is a part. We urge you to read that registration statement in
its entirety, including all amendments, exhibits, schedules and supplements to that registration statement, which can be obtained from
the Commission as described below under the caption "Where You Can Find More Information." You may also obtain the information
we incorporate by reference into this prospectus without charge by following the instructions below under the caption "Incorporation
of Certain Information by Reference."
The distribution of this prospectus
may be restricted by law in certain jurisdictions. You should inform yourself about and observe any of these restrictions. We are not
(and any selling shareholders are not), making an offer to sell or soliciting an offer to buy these securities in any jurisdiction where
the offer or sale is not permitted, or where the person making the offer or solicitation is not qualified to do so, or to any person to
whom it is unlawful to make the offer or solicitation.
In making an investment decision,
you must rely on your own examination of our Company and the terms of the offering and the securities, including the merits and risks
involved.
We are not making any representation
to any purchaser of the securities registered hereby regarding the legality of an investment in the securities by such purchaser. You
should not consider any information in this prospectus to be legal, business or tax advice, and you should consult your own legal, business
and tax advisors for advice regarding an investment in the securities offered hereby.
In this prospectus, unless
we state otherwise, all dollar amounts in this prospectus are expressed in United States (U.S.) dollars, and all references to "U.S.$"
or "$" are to U.S. dollars.
|
PROSPECTUS SUMMARY
This section summarizes some of the information
that is contained later in this prospectus or in other documents incorporated by reference into this prospectus. As an investor or prospective
investor, you should review carefully the risk factors and the more detailed information appearing later in this prospectus or contained
in the documents that we incorporate by reference into this prospectus.
Our Business
We deliver innovative supply chain solutions globally
to customers in two operating and reporting segments: Advanced Technology Solutions ("ATS") and Connectivity and Cloud Solutions
("CCS").
Our ATS segment consists of our ATS end market,
and is comprised of our aerospace and defense ("A&D"), Industrial, HealthTech, and Capital Equipment businesses. Our Capital
Equipment business is comprised of our semiconductor and display businesses. Our CCS segment consists of our Communications and Enterprise
end markets. Our Enterprise end market is comprised of our servers and storage businesses.
Our customers include original equipment manufacturers
("OEMs"), cloud-based and other service providers, including hyperscalers, and other companies in a wide range of industries.
Our global headquarters is located in Toronto, Ontario, Canada. We operate a network of sites and centers of excellence strategically
located in North America, Europe and Asia, with specialized end-to-end supply chain capabilities tailored to meet specific market and
customer product lifecycle requirements.
We offer a comprehensive range of product manufacturing
and related supply chain services to customers in both of our segments, including design and development, new product introduction, engineering
services, component sourcing, electronics manufacturing and assembly, testing, complex mechanical assembly, systems integration, precision
machining, order fulfillment, logistics, product licensing, and after-market repair and return and IT asset management and disposition
("ITAM/ITAD") services. Our Hardware Platform Solutions ("HPS") offering, within our CCS segment, includes the development
of infrastructure platforms, hardware and software design solutions, including open-source software that complements our hardware offerings,
and services that can be used as-is, or customized for specific applications in collaboration with our customers, and management of program
design and aspects of the supply chain, manufacturing, and after-market support, including ITAM/ITAD.
We believe our services and solutions create value
for our customers by enabling their strategies, while accelerating their time-to-market, and by providing higher quality, lower cost,
and reduced cycle times (as compared to insourcing) in our customers' supply chains. We believe this results in lower total cost of ownership,
greater flexibility, higher returns on invested capital and improved competitive advantage for our customers in their respective markets.
Products and services
in our ATS segment are extensive and are often more regulated than in our CCS segment, and can include the following: government-certified
and highly-specialized manufacturing, electronic and enclosure-related services for A&D customers; high-precision semiconductor and
display equipment and integrated subsystems; a wide range of industrial automation, controls, test and measurement devices; engineering-focused
engagements, including in the areas of telematics, human machine interface, Internet-of-Things and embedded systems; advanced solutions
for surgical instruments, diagnostic imaging and patient monitoring; and efficiency products to help manage and monitor the energy and
power industries. Products and services in our CCS segment consist predominantly of enterprise-level data communications and information
processing infrastructure products and systems, and can include routers, switches, data center interconnects, edge solutions, servers
and storage-related products used by a wide range of businesses and cloud-based and other service providers to manage digital connectivity,
commerce and social media applications. Our ATS segment businesses typically have higher margin profiles and margin volatility, higher
working capital requirements, lower volumes and longer product lifecycles than the traditional businesses in our CCS segment. Within
our CCS segment, however, our HPS business (which includes firmware/software enablement across all primary IT infrastructure data center
technologies, open-source software offerings that complement our hardware platforms, and after-market services, including ITAM/ITAD)
typically has a higher margin profile than our traditional CCS businesses, but also requires specific investments (including research
and development ("R&D")) and higher working capital. Our CCS segment generally experiences a high degree of volatility
in terms of revenue and product/service mix, and as a result, our CCS segment margin can fluctuate from period to period. In recent periods,
we have experienced an increasing shift in the mix of our programs towards cloud-based and other service providers, which are cyclically
different from our traditional OEM customers, creating more volatility and unpredictability in our revenue patterns, and additional challenges
with respect to the management of our supply chain and working capital requirements.
|
|
We remain committed to making the investments
we deem necessary to support our long-term growth strategy, strengthen our competitive position, enhance customer satisfaction, and increase
long-term shareholder value. Within both of our segments, we are focused on: increased penetration in our end markets; diversifying our
customer mix and product portfolios, including increasing design and development, engineering, and after-market services (higher value-added
services); and diversifying our capabilities and supply chain. We intend to continue to expand our business by growing our CCS segment,
focusing on our HPS business, high-value EMS programs (including with hyperscalers) and services, and by continuing to pursue new customers
and acquisition opportunities in both of our segments.
Corporate Information
We were incorporated in Ontario, Canada on September
27, 1996. We are a corporation domiciled in the Province of Ontario, Canada and operate under the Business Corporations Act (Ontario)
(the "OBCA"). Our principal executive offices are located at 5140 Yonge Street, Suite 1900, Toronto, Ontario, Canada M2N 6L7.
Our telephone number is (416) 448-5800.
Prior to our incorporation, we were an IBM manufacturing
unit that provided manufacturing services to IBM for more than 75 years. In 1993, we began providing electronics manufacturing services
to non-IBM customers. In October 1996, we were purchased from IBM by an investor group led by Onex Corporation ("Onex"), and
in 1998, we completed our initial public offering. In June 2023 and August 2023, Onex (our then-controlling shareholder), completed underwritten
secondary public offerings of an aggregate of approximately 18.8 million of our Subordinate Voting Shares (now designated common shares).
In connection with such offerings, we converted all of our outstanding multiple voting shares ("MVS") into Subordinate Voting
Shares (now designated common shares). Subsequent to the August 2023 secondary offering, we have no MVS outstanding and Onex is no longer
our controlling shareholder.
Our common shares are listed on the New York Stock
Exchange and the Toronto Stock Exchange, and trade under the symbol "CLS."
The Securities
We
may use this prospectus to offer: common shares; preferred shares; debt securities (consisting of senior or subordinated, and/or
secured or unsecured, debentures, notes or other evidences of indebtedness); and/or warrants to purchase common shares, preferred shares,
debt securities or other securities. This prospectus may also be used by our shareholders to offer our common shares. Our debt securities
may be guaranteed by one or more of our subsidiaries.
A prospectus supplement will describe the specific
types, amounts, prices, and detailed terms of any of these offered securities and may describe certain risks in addition to those described
herein associated with an investment in the securities.
Listing
If any securities are to be listed or quoted on
a securities exchange or quotation system, the applicable prospectus supplement will say so.
Net Proceeds
Unless otherwise indicated in an accompanying
prospectus supplement, we will use the net proceeds from our sale of any securities for general corporate purposes. We will not receive
any proceeds from the sale of our common shares by any selling shareholders. |
CAUTIONARY NOTE ON FORWARD-LOOKING STATEMENTS
In addition to historical
information, this prospectus (and any prospectus supplement) and the documents we incorporate by reference in this prospectus (and in
any prospectus supplement) contain "forward-looking statements" within the meaning of Section 27A of the U.S. Securities Act
of 1933, as amended (the "Securities Act"), Section 21E of the U.S. Securities Exchange Act of 1934, as amended, (the "Exchange
Act"), and forward-looking information within the meaning of applicable Canadian securities laws (collectively, "forward-looking
statements"), including, without limitation, statements related to: our priorities, intended areas of focus, targets, objectives
and goals; trends in the electronics manufacturing services ("EMS") industry and our segments (and/or their constituent businesses)
and their anticipated impact; the anticipated impact of current market conditions and customer-specific factors on each of our segments
(and/or their constituent businesses) and near term expectations; potential restructuring and divestiture actions; our anticipated financial
and/or operating results and outlook, including expected revenue increases and decreases (or remaining flat), as well as growth in certain
businesses and end markets; our strategies; our credit risk; the potential impact of acquisitions, or program wins, transfers, losses
or disengagements; materials, component and supply chain constraints; anticipated expenses, capital expenditures and other working capital
requirements and contractual obligations (and intended methods of funding such items); the potential impact of trade policies between
countries in which we conduct business (including the potential tariffs implemented by U.S. government); the impact of our price reductions
and longer payment terms; our intended repatriation of certain undistributed earnings from non-Canadian subsidiaries (and amounts we do
not intend to repatriate in the foreseeable future); the potential impact of tax and litigation outcomes; investor dissatisfaction with
inclusion, employee engagement, and other environmental, social and governance ("ESG") matters; our intention to settle employee
share unit awards in common shares ("Common Shares"); our ability to use certain tax losses; intended investments in our business;
the potential impact of the pace of technological changes, customer outsourcing, program transfers, and the global economic environment;
the intended method of funding Common Share repurchases; the impact of our outstanding indebtedness; liquidity and the sufficiency of
our capital resources; our intention to settle outstanding equity awards with Common Shares; our financial statement estimates and assumptions;
recently-issued accounting pronouncements and amendments; the potential adverse impacts of events outside of our control; mandatory prepayments
under our credit facility; pension plan funding requirements and obligations, and the impact of annuity purchases; our compliance with
covenants under our credit facility; refinancing debt at maturity; interest rates and expense; income tax incentives; accounts payable
cash flow levels; accounts receivable sales; expectations with respect to reporting units with goodwill; our future warranty obligations;
cybersecurity threats and incidents; our intentions with respect to environmental assessments for newly-leased or acquired properties;
our expectations with respect to expiring leases; our intention to retain earnings for general corporate purposes; costs in connection
with our pursuit of acquisitions and strategic transactions; and expectations regarding the acceptance of offers to sell accounts receivable
("A/R") under our A/R sales programs and supplier financing programs. Also, documents which we subsequently file with the Commission
and are incorporated herein by reference will contain such forward-looking statements. Forward-looking statements may, without limitation,
be preceded by, followed by, or include words such as "believes," "expects," "anticipates," "estimates,"
"intends," "plans," "continues," "project," "target," "objective," "goal,"
"potential," "possible," "contemplate," "seek," or similar expressions, or may employ such future
or conditional verbs as "may," "might," "will," "could," "should" or "would,"
or may otherwise be indicated as forward-looking statements by grammatical construction, phrasing or context. In addition, any statements
concerning future financial performance, ongoing business strategies or prospects, and possible future actions, which may be provided,
are also forward-looking statements. For forward-looking statements, we claim the protection of the safe harbor for forward-looking statements
contained in the U.S. Private Securities Litigation Reform Act of 1995, and for forward-looking information under applicable Canadian
securities laws.
Forward-looking statements
contained in this prospectus (and any prospectus supplement) and the documents we incorporate by reference in this prospectus (and in
any prospectus supplement) are based on various assumptions, many of which involve factors that are beyond our control. Our material assumptions
include: growth in manufacturing outsourcing from customers in diversified markets; our ability to retain programs and customers, including
no unexpected customer or program transfers, losses or disengagements; no unforeseen adverse changes in our mix of businesses; no undue
negative impact on our customers' ability to compete and succeed using products we manufacture and services we provide; continued growth
in our end markets; our ability to successfully diversify our customer base and develop new capabilities; anticipated demand levels across
our businesses; continued growth in the advancement and commercialization of artificial intelligence ("AI") technologies and
cloud computing; supporting sustained high levels of capital expenditure investments by leading hyperscaler, AI and data center customers;
no significant unforeseen negative impacts to our operations; no unforeseen materials price increases, margin pressures, or other competitive
factors affecting the EMS or original design manufacturer industries in general or our segments in particular; compliance by third parties
with their contractual obligations; that our customers will retain liability for product/component tariffs and countermeasures; our ability
to keep pace with rapidly changing technological developments; the successful resolution of quality issues that arise from time to time;
fluctuation of production schedules from our customers in terms of volume and mix of products or services; the timing and execution of,
and investments associated with, ramping new business; supplier performance and quality, pricing and terms; the costs and availability
of components, materials, services, equipment, labor, energy and transportation; no significant decline in the global economy or in economic
activity in our end markets due to a major recession or otherwise; no unforeseen disruptions due to geopolitical factors (including war)
causing significant negative impacts to economic activity, global or regional supply chains or normal business operations; that global
inflation will not have a material impact on our revenues or expenses; the impact of anticipated market conditions on our businesses;
the stability of currency exchange rates; the availability of capital resources for, and the permissibility under our credit facility
of, repurchases of outstanding Common Shares under our current normal course issuer bid ("NCIB"), and compliance with applicable
laws and regulations pertaining to NCIBs; compliance with applicable credit facility covenants and the components of our leverage ratios
(as defined in our credit facility); our maintenance of sufficient financial resources to fund currently anticipated financial actions
and obligations and to pursue desirable business opportunities; global tax legislation changes; the timing, execution and effect of restructuring
actions; and no unforeseen adverse changes in the regulatory environment.
Forward-looking statements
are not guarantees of future performance and the Company's actual results may differ significantly from the results discussed in the forward-looking
statements. Achievement of anticipated results is subject to substantial risks, uncertainties and inaccurate assumptions. Should known
or unknown risks or uncertainties materialize, or should underlying assumptions prove inaccurate, actual results could vary materially
from past results and those anticipated, estimated or projected. You should bear this in mind as you consider forward-looking statements,
and you are cautioned not to put undue reliance on forward-looking statements. Forward-looking statements speak only as of the date on
which they are made, and we undertake no obligation to publicly update forward-looking statements, whether as a result of new information,
future events or otherwise, except as required by law or by the rules and regulations of the Commission. You are advised, however, to
consult any further disclosures we make on related subjects. A detailed discussion of these and other risks and uncertainties that could
cause actual results and events to differ materially from such forward-looking statements is included in Part I, Item 1A of our most recent
Annual Report on Form 10-K and in any subsequent Quarterly Reports on Form 10-Q in the section titled "Risk Factors" and as
may be included from time to time in our reports filed with the Commission.
RISK FACTORS
Before making an investment
decision, you should carefully consider the risks described in the section captioned "Risk Factors" in any applicable prospectus
supplement, as well as those set forth in documents we incorporate by reference in this prospectus and any applicable prospectus supplement,
including the "Risk Factors" section of our most recent Annual Report on Form 10-K, and any updates to those Risk Factors in
subsequently filed Quarterly Reports on Form 10-Q or Current Reports on Form 8-K that we incorporate by reference in this prospectus and
any applicable prospectus supplement, together with all of the other information appearing in this prospectus and any applicable prospectus
supplement. Each of the risks described in these sections and documents could materially and adversely affect our business, financial
condition, results of operations and prospects. Additional unknown risks and uncertainties, or those that we deem immaterial, may also
impair our business, financial condition, results of operations and prospects. The trading price of our securities could decline due to
any of these risks, and you may lose all or part of your investment.
Please see "Where You
Can Find More Information" and "Incorporation of Certain Information by Reference" for information on where you can find
the documents we have filed with or furnished to the Commission and which documents are incorporated into this prospectus by reference.
USE OF PROCEEDS
We will retain broad discretion
over the use of the net proceeds from the sale of our securities under this prospectus. Unless we specify otherwise in any prospectus
supplement, we intend to use the net proceeds from the sale of the securities covered by this prospectus for general corporate purposes,
including, without limitation, working capital, the repayment of existing debt, and/or financing capital investments or acquisitions.
We may temporarily invest funds that we do not need immediately for these purposes in short-term marketable securities. We will not receive
any proceeds from the sale of common shares by any selling shareholders.
DESCRIPTION OF SHARE CAPITAL
The rights of our shareholders
are governed by the OBCA, our Restated Articles of Incorporation ("Articles"), and our by-laws ("By-laws"). Our authorized
share capital consists of an unlimited number of common shares, without nominal or par value, and an unlimited number of preferred shares,
issuable in series, without nominal or par value. The following description is a summary of the material terms of our common shares. You
should refer to each of our Articles and By-laws for complete information regarding its respective provisions, copies of which are incorporated
by reference as exhibits to the Registration Statement of which this prospectus forms a part.
Common Shares
Dividends. Subject to the prior rights of
the holders of preferred shares, the holders of common shares shall be entitled to receive dividends, and the Company shall pay dividends
on the common shares, as and when declared by the board of directors of the Company (the "Board"), in such amount and in such
form as the Board may from time to time determine.
Voting
Rights. The holders of the common shares shall be entitled to receive notice of and to attend all meetings of shareholders
of the Company, and to vote together at all such meetings, except meetings at which only the holders of one class or series of shares
are entitled to vote separately as a class or series, as the case may be. The holders of common shares shall be entitled to one vote per
share at any meeting of holders of common shares at which they are entitled to vote separately as a class. Generally, all matters to be
voted on by shareholders must be approved by a simple majority (or, in the case of election of directors where the number of candidates
nominated for election exceeds the number of directors to be elected, by a plurality, and in the case of an amalgamation or amendments
to our Articles, by two-thirds) of the votes cast in respect of common shares held by persons present in person or by proxy, voting together.
Rights
on Dissolution. In the event of the liquidation, dissolution or winding-up of the Company, whether voluntary or involuntary,
or any other distribution of the assets of the Company among its shareholders for the purpose of winding-up its affairs, subject to the
prior rights of the holders of preferred shares, the holders of the common shares then outstanding shall be entitled to receive the remaining
property and assets of the Company rateably according to the number of common shares held by each holder.
Other Rights. The common
shares are not redeemable, nor do the holders of such shares have pre-emptive purchase rights. Directors do not stand for re-election
at staggered intervals. Other than under applicable securities laws, there are no restrictions on the transferability of common shares.
Substantial
Shareholders. There are no provisions in the Articles or the Company's By-laws discriminating against any existing or prospective
holder of our securities as a result of such shareholder owning a substantial number of our securities.
However, transactions involving
shareholders that hold a substantial number of securities may be subject to Multilateral Instrument 61-101 Protection of Minority Security
Holders in Special Transactions ("MI 61-101"). MI 61-101 contains requirements in connection with certain types of transactions
including related party transactions. Related party transactions include, for an issuer, certain types of transactions between the issuer
and a person that is a related party of the issuer at the time the transaction is agreed to, whether or not there are also other parties
to the transaction. Related parties of an issuer include, among others, control persons of the issuer, directors, senior officers and
persons that have beneficial ownership or control or direction over (or a combination thereof), directly or indirectly, 10% of the voting
securities of the issuer.
Subject to the availability
of certain exemptions, MI 61-101 provides certain procedural protections for minority or disinterested shareholders in connection with
the types of transactions that are subject to MI 61-101. In particular, MI 61-101 requires, subject to certain exemptions: (i) more detailed
disclosure in the proxy material sent to security holders in connection with a transaction; (ii) the preparation of a formal valuation
of the subject matter of the transaction; and (iii) minority approval of the proposed transaction by a majority of the votes cast by minority
or disinterested shareholders.
Modification,
Sub-division and Consolidation. Any modification to the provisions attaching to the common shares requires the affirmative
vote of two-thirds of the votes cast by the holders of common shares.
Creation
of Other Voting Shares. The Company may not create any class or series of shares, or issue any shares of any class or series
(other than common shares) having the right to vote generally on all matters that may be submitted to a vote of shareholders (except matters
for which applicable law requires the approval of holders of another class or series of shares voting separately as a class or series)
without the separate affirmative vote of two-thirds of the votes cast by the holders of common shares.
Change
of Control. There are no provisions in the Articles or our By-laws that have been adopted in order to have the effect of delaying,
deferring or preventing a change in control of the Company and that operate only with respect to an extraordinary corporate transaction
involving the Company (or any of its subsidiaries), such as a merger, reorganization, tender offer, sale or transfer or substantially
all of its assets, or liquidation.
Changes
in the Capital of the Company. There are no provisions in the Articles or our By-laws which are more stringent than those required
by the OBCA.
Advance
Notice By-law. The Company's advance notice by-law (the "Advance Notice By-Law"), among other things, provides that
shareholders seeking to nominate, in compliance with the Advance Notice By-Law, candidates for election as directors must give timely
notice in writing to the Corporate Secretary of the Company. The Advance Notice By-Law does not interfere with the ability of shareholders
to requisition a meeting or to nominate directors by way of a shareholder proposal in accordance with the OBCA. To be timely, such notice
must be properly given (i) in the case of an annual meeting (including an annual and special meeting) of shareholders, not less than 30
days prior to the date of the meeting; provided, however, that in the event that the meeting is to be held on a date that is less than
50 days after the date (the "Notice Date") on which the first disclosure in a press release reported by a national news service
in Canada, or in a document publicly filed by the Corporation under its profile both on SEDAR+ at www.sedarplus.com and on EDGAR at www.sec.gov,of
the date of the meeting was made, notice by the nominating shareholder must be properly given not later than the close of business on
the tenth day following the Notice Date; (ii) in the case of a special meeting (which is not also an annual meeting) of shareholders called
for the purpose of electing directors (whether or not also called for other purposes), not later than the close of business on the fifteenth
day following the Notice Date; and (iii) notwithstanding the foregoing, in the case of an annual meeting of shareholders or a special
meeting (which is not also an annual meeting) of shareholders called for the purpose of electing directors (whether or not also called
for other purposes) where "notice-and-access" is used for delivery of proxy-related materials and the Notice Date is not less
than 50 days before the date of the meeting, not less than 40 days prior to the date of the meeting.
The Advance Notice By-Law
also prescribes the proper written form for a shareholder's notice as well as additional requirements in connection with nominations.
Except as otherwise provided by applicable law and the Articles, no person will be eligible for election as a director of the Company
unless nominated in accordance with the provisions of the Company's Advance Notice By-Law.
The Advance Notice By-Law
authorizes the chair of the meeting to determine whether a nomination was made in accordance with the procedures set forth in the Advance
Notice By-Law and, if any proposed nomination is not in compliance with the Advance Notice By-Law, to declare that such defective nomination
shall be disregarded. The Board may, in its sole discretion, waive any requirements of the Advance Notice By-Law.
Rights
to Own Securities. There are no limitations under our Articles, By-laws or in the OBCA on the rights to own our securities,
including the rights of non-resident or foreign shareholders to hold or exercise voting rights on our securities, except that certain
transactions under the Investment Canada Act may require that a "non-Canadian" not acquire "control" of the Company
without prior review and approval by the Minister of Innovation, Science and Industry. The acquisition of one-third or more of the voting
shares of the Company would give rise to a rebuttable presumption of the acquisition of control, and the acquisition of more than fifty
percent of the voting shares of the Company would constitute an acquisition of control. In addition, the Investment Canada Act provides
the Canadian government with broad discretionary powers in relation to national security to review and potentially prohibit, condition
or require the divestiture of, any investment in the Company by a non-Canadian, including non-control level investments. "Non-Canadian"
generally means an individual who is neither a Canadian citizen nor a permanent resident of Canada within the meaning of the Immigration
and Refugee Protection Act (Canada) who has been ordinarily resident in Canada for not more than one year after the time at which he or
she first became eligible to apply for Canadian citizenship, or a corporation, partnership, trust or joint venture that is ultimately
controlled by non-Canadians.
In addition, limitations on
the ability to acquire and hold shares of the Company may be imposed by the Competition Act (Canada) (the "Competition Act").
This legislation grants the Commissioner of Competition (the "Commissioner") jurisdiction, for up to three years, to challenge
the acquisition of an interest in us before the Competition Tribunal if the Commissioner believes that it would, or would be likely to,
result in a substantial lessening or prevention of competition in any market in Canada. The Competition Act requires that any person proposing
to acquire any of the assets in Canada of an operating business file a notification with the Competition Bureau where specified "size
of the parties" and "size of the transaction" thresholds are exceeded. In the case of share acquisitions, an additional
"shareholding threshold" applies. Any person who intends to acquire shares must file a notification with the Competition Bureau
if certain financial thresholds are exceeded, and that person would hold more than 20% of our voting shares as a result of the acquisition.
If a person already owns more than 20% of our voting shares, a notification must be filed when the acquisition would bring that person's
holdings over 50%. Where a notification is required, the legislation prohibits completion of the acquisition until the expiration of a
statutory waiting period or unless the Commissioner waives the waiting period.
Preferred Shares
The Company's Board may issue
preferred shares from time to time in one or more series, and (subject to the provisions of the Articles) determine the designation of,
and the rights, privileges, restrictions and conditions attaching to, such shares (including, without limitation, dividend rights, cancellation,
retraction or redemption rights, voting rights, conversion or exchange rights, sinking fund provisions and/or other provisions). Preferred
shares of each series will rank as to dividends (to the extent cumulative dividends are applicable) and capital on a parity with preferred
shares of every other series. Preferred shares of each series will rank as to dividends and capital senior to the common shares.
With respect to a distribution of assets in the
event of a liquidation, dissolution or winding-up of the Company, whether voluntary or involuntary, or any other distribution of the assets
of the Company for the purpose of winding up its affairs, holders of preferred shares of each series will be entitled to receive from
the assets of the Company in respect of each such share held a sum equal to the amount in the stated capital account for such series divided
by the number of shares in such series then outstanding, together with any accrued (in the case of cumulative dividends) or declared (in
the case of non-cumulative dividends) and unpaid dividends thereon, before any amount shall be paid or any assets are distributed to the
holders of common shares. Upon the receipt of such sum, the holders of preferred shares shall not be entitled to share in the distribution
of our remaining assets and their preferred shares will be canceled.
There are currently no preferred shares outstanding.
The material terms of any
preferred shares that we offer through a prospectus supplement will be described in that prospectus supplement.
DESCRIPTION OF OTHER SECURITIES
Description of Debt Securities
The following is a general
description of the debt securities which may be issued from time to time by us under this prospectus. The particular terms of any debt
securities offered will be described in a prospectus supplement.
The Indenture
The debt securities covered
by this prospectus may be issued in one or more series under an indenture dated as of a date on or prior to the issuance of the debt securities
to which it relates between us and the trustee named therein, and pursuant to an applicable prospectus supplement. The form of the indenture
has been filed as an exhibit to the registration statement of which this prospectus is a part. If we issue debt securities, we will file
any final indenture and any supplemental indenture or officer's certificate related to the particular series of debt securities issued
with the Commission, and you should read those documents for further information about the terms and provisions of such debt securities.
See "Where You Can Find More Information." We refer to such indenture, as amended or supplemented from time to time, as the
"Indenture." The Indenture will be subject to, and governed by, the United States Trust Indenture Act of 1939, as amended (the
"Trust Indenture Act").
The following description
sets forth certain general terms and provisions of the debt securities and the Indenture. The statements below are not complete and are
subject to, and are qualified in their entirety by reference to, all of the provisions of the Indenture. This summary is also subject
to, and qualified by, the description of the particular terms and provisions of the debt securities included in the applicable prospectus
supplement. The applicable prospectus supplement may add to, update or change the general terms described below. Accordingly, you should
read the summary below, the applicable prospectus supplement, the provisions of the Indenture (including any applicable supplement thereto),
and any related documents before investing in our debt securities. If there is any inconsistency between the terms presented here and
those in the applicable prospectus supplement, the terms of the prospectus supplement will supersede the terms presented here.
Certain of our subsidiaries
may guarantee the debt securities we offer. Those guarantees may or may not be secured by liens, mortgages, and security interests in
the assets of those subsidiaries. The terms and conditions of any such subsidiary guarantees, and a description of any such liens, mortgages
or security interests, will be set forth in a prospectus supplement.
There is no requirement under
the Indenture that future issues of our debt securities be issued under such Indenture, and we will be free to use other indentures or
documentation containing provisions different from those included in the Indenture or applicable to one or more series of debt securities,
in connection with future issues of such other debt securities.
References to "us"
or "we" in this description of debt securities means Celestica Inc., but not any of our subsidiaries.
General
The Indenture permits us to
issue from time to time senior or subordinated, secured or unsecured, debentures, notes or other evidences of indebtedness, issuable in
one or more series (with the same or various maturities, at par, at a premium or at a discount), which may be convertible into or exchangeable
for any securities of any person (including us). The Indenture permits us to establish the terms of each series of debt securities at
the time of issuance, and does not limit the aggregate amount of debt securities that we may issue thereunder. The prospectus supplement
relating to any series of debt securities that we may offer will contain the specific terms of the debt securities. Those specific terms
will include the following:
| · | the title of the debt securities; |
| · | the price or prices at which we will issue the debt securities; |
| · | the price or prices at which we will issue the debt securities; |
| · | any limit upon the aggregate principal amount of the debt securities; |
| · | the date or dates on which we will pay the principal of the debt securities; |
| · | the rate or rates (which may be fixed or variable) per annum or the method used to determine such rate
or rates (including, but not limited to, any commodity, commodity index, stock exchange index or financial index) at which the debt securities
will bear interest, the date or dates from which such interest, if any, will accrue, the date or dates on which such interest, if any,
will commence and be payable and any regular record date for the interest payable on any interest payment date; |
| · | the place or places where the principal of, premium, if any, and interest, if any, on the debt securities
will be payable; |
| · | the terms and conditions upon which we may redeem the debt securities; |
| · | any obligation we have to redeem or purchase the debt securities pursuant to any sinking fund or analogous
provisions or at the option of a holder thereof; |
| · | any dates on which and the price or prices at which we will repurchase the debt securities at the option
of the holders thereof and other detailed terms and provisions of any such repurchase obligations; |
| · | the denominations in which the debt securities will be issuable, if other than minimum denominations of
$2,000 and integral multiples of $1,000 in excess thereof; |
| · | whether the debt securities will be issued in bearer or fully registered form (and, if in fully registered
form, whether the debt securities will be issuable as global debt securities); |
| · | if other than the principal amount thereof, the portion of the principal amount of the debt securities
that will be payable upon declaration of acceleration of the maturity date; |
| · | whether the debt securities will be "original issue discount" securities for United States federal
income tax purposes; |
| · | the designation of the currency or currencies in which payment of the principal of, premium and interest,
if any, on the debt securities will be made if other than United States dollars; |
| · | whether, under what circumstances, and the currency in which the Company will pay certain additional amounts
to holders who are not Canadian persons in respect of specified tax, assessment or governmental charges and, if so, whether we will have
the option to redeem such debt securities rather than pay such additional amounts (and the terms of any such option); |
| · | the provisions, if any, relating to any security provided for the debt securities; |
| · | whether the debt securities will be senior debt securities or subordinated debt securities, and if they
are subordinated, the terms of the subordination; |
| · | whether payments on the debt securities may be made, at our or the holder's election, in a currency other
than that in which such debt securities are stated to be payable, and the manner of determining the applicable exchange rate; |
| · | the terms of any guarantee of payment obligations with respect to the debt securities and any corresponding
changes to the provisions of this Indenture as then in effect; |
| · | if the debt securities are to be convertible into or exchangeable for any securities (including those
of the Company), the terms and conditions of any such conversion or exchange; |
| · | provisions for electronic issuances of debt securities or debt securities in uncertificated form; |
| · | any addition to or change in the events of default or the acceleration provisions described in the Indenture
with respect to the debt securities; |
| · | any addition to or change in the covenants described in the Indenture with respect to the debt securities; |
| · | any selling restrictions applicable to the debt securities, if any; |
| · | any other terms of the debt securities which may modify or delete any provision of the Indenture as it
applies to such debt securities; and |
| · | any depositaries, interest rate calculation agents, exchange rate calculation agents or other agents with
respect to the debt securities if other than those appointed in the Indenture. |
We may issue additional debt
securities of a particular series without the consent of the holders of the debt securities of such series outstanding at the time of
issuance. In addition, we will describe in the applicable prospectus supplement material U.S. federal tax considerations and any other
special considerations for any debt securities we sell which are denominated in a currency or currency unit other than U.S. dollars.
Except as specifically described
in the applicable prospectus supplement, the Indenture does not contain any covenants designed to protect holders of the debt securities
against a reduction in our creditworthiness in the event of a highly leveraged transaction or to prohibit other transactions which may
adversely affect holders of the debt securities.
Exchange and Transfer
Debt securities may be transferred
or exchanged at the office of the registrar or co-registrar designated by us.
We will not impose a service
charge for any transfer or exchange, but we may require holders to pay any tax or other governmental charges associated with any transfer
or exchange.
In the event of
any redemption of debt securities of any series, we will not be required to:
| · | issue, register the transfer of, or exchange, any debt security of that series during a specified period
before sending a notice of redemption; or |
| · | register the transfer of or, exchange any, debt security of that series selected, called or being called
for redemption, in whole or in part, except the unredeemed portion of any series being redeemed in part. |
We may initially appoint the
trustee as the registrar. Any transfer agent, in addition to the registrar initially designated by us, will be named in the prospectus
supplement. We may designate additional transfer agents or change transfer agents or change the office of the transfer agent. However,
we will be required to maintain a transfer agent in each place of payment for the debt securities of each series.
Global Securities
The debt securities of any
series may be represented, in whole or in part, by one or more global securities. Each global security will:
| · | be registered in the name of a depositary that we will identify in a prospectus supplement; |
| · | be deposited with the trustee as custodian for the depositary or its nominee; and |
| · | bear any required legends. |
No global security may be
exchanged in whole or in part for debt securities registered in the name of any person other than the depositary or any nominee unless:
| · | the depositary has notified us that it is unwilling or unable to continue as depositary or has ceased
to be qualified to act as depositary, and in either case we fail to appoint a successor depositary registered as a clearing agency under
the Exchange Act within 90 days of such event; |
| · | we execute and deliver to the trustee an officer's certificate to the effect that such global securities
shall be so exchangeable; or |
| · | an event of default with respect to the debt securities represented by such global securities shall have
occurred and be continuing. |
As long as the depositary,
or its nominee, is the registered owner of a global security, the depositary or nominee will be considered the sole owner and holder of
the debt securities represented by the global security for all purposes under the Indenture. Except in the above limited circumstances,
owners of beneficial interests in a global security:
| · | will not be entitled to have the debt securities registered in their names; |
| · | will not be entitled to physical delivery of certificated debt securities; and |
| · | will not be considered to be holders of those debt securities under the Indenture. |
Payments on a global security
will be made to the depositary or its nominee as the holder of the global security. Some jurisdictions have laws that require that certain
purchasers of securities take physical delivery of such securities in definitive form. These laws may impair the ability to transfer beneficial
interests in a global security.
Institutions that have accounts
with the depositary or its nominee are referred to as "participants." Ownership of beneficial interests in a global security
will be limited to participants and to persons that may hold beneficial interests through participants. The depositary will credit, on
its book-entry registration and transfer system, the respective principal amounts of debt securities represented by the global security
to the accounts of its participants. Each person owning a beneficial interest in a global security must rely on the procedures of the
depositary (and, if such person is not a participant, on procedures of the participant through which such person owns its interest) to
exercise any rights of a holder under the Indenture.
Ownership of beneficial interests
in a global security will be shown on and effected through records maintained by the depositary, with respect to participants' interests,
or by any participant, with respect to interests of persons held by participants on their behalf. Payments, transfers and exchanges relating
to beneficial interests in a global security will be subject to policies and procedures of the depositary. The depositary's policies and
procedures may change from time to time. Neither we nor the trustee will have any responsibility or liability for the depositary's acts
or omissions or any participant's records with respect to beneficial interests in a global security.
Payment and Paying Agent
The provisions of this subsection
will apply to the debt securities unless otherwise indicated in the prospectus supplement. Payment of interest on a debt security on any
interest payment date will be made to the person in whose name the debt security is registered at the close of business on the regular
record date. Payment on debt securities of a particular series will be payable at the office of a paying agent or paying agents designated
by us. However, at our option, we may pay interest by mailing a check to the record holder.
We may also name any other
paying agents in the prospectus supplement. We may designate additional paying agents, change paying agents or change the office of any
paying agent. However, we will be required to maintain a paying agent in each place of payment for the debt securities of a particular
series.
Subject to any applicable
abandoned property law, all moneys paid by us to a paying agent for payment on any debt security that remain unclaimed at the end of two
years after such payment was due will be repaid to us. Thereafter, the holder may look only to us for such payment.
Covenants
Any series of debt securities
may have covenants in addition to or differing from those included in the Indenture, limiting or restricting, among other things: our
ability to incur either secured or unsecured debt, or both; our ability to make certain payments, dividends, redemptions or repurchases;
our ability to create dividend and other payment restrictions affecting our subsidiaries; our ability to make investments; mergers and
consolidations by us or our subsidiaries; sales of assets by us; our ability to enter into transactions with affiliates; our ability to
incur liens; and/or sale and leaseback transactions. Any such additional or different covenants will be described in the applicable prospectus
supplement.
Events of Default
Each of the following constitutes
an event of default for a series of debt securities unless it is either inapplicable to a particular series or it is specifically deleted
or modified:
| · | default for 30 days in the payment of any interest when due; |
| · | default in the payment of principal, or premium, if any, when due at maturity, upon acceleration, declaration
or redemption or otherwise; |
| · | default in the performance, or breach, of any covenant or warranty in the Indenture (or applicable board
resolution or officer's certificate) for 90 days after specified written notice; |
| · | certain events of bankruptcy, insolvency or reorganization; and |
| · | any other event of default provided with respect to debt securities of that series. |
We are required to furnish
the trustee annually with an officer's certificate as to our compliance with all conditions and covenants under the Indenture. The Indenture
provides that the trustee may withhold notice to holders of debt securities of any default, except in respect of the payment of the principal
of, premium, if any, or interest on the debt securities, if it considers it in the interests of the holders of the debt securities to
do so.
Effect of an Event of Default
If
an event of default exists with respect to debt securities of any series (other than an event of default in the case of certain events
of bankruptcy set forth in the Indenture), the trustee or the holders of a specified percentage in aggregate principal amount of such
series outstanding may declare the principal amount of, and all accrued but unpaid interest, if any, on all outstanding debt securities
of that series to be due and payable immediately, by a notice in writing to us, and to the trustee if given by holders. Upon that declaration,
such amounts will become immediately due and payable. However, at any time after a declaration of acceleration has been made, but before
a judgment or decree for payment of the money due has been obtained, the holders of a majority in principal amount of the outstanding
securities of that series, by written notice to us and the trustee, may rescind and annul such declaration and consequences, subject to
conditions specified in the Indenture. If an event of default in the case of certain events of bankruptcy, insolvency or reorganization
exists, the principal amount of, and accrued and unpaid interest, if any, on all debt securities outstanding under the Indenture shall
automatically, and without any declaration or other action on the part of the trustee or any holder of such outstanding debt, become immediately
due and payable.
Legal Proceedings and Enforcement of Right to Payment
Holders of any series of debt
securities may not pursue any remedy with respect to the Indenture or such debt securities unless: (i) they have given to the trustee
written notice of a continuing event of default with respect to debt securities of that series; (ii) holders of a specified percentage
of the aggregate principal amount of the then-outstanding debt securities of that series make a written request to the trustee to pursue
the remedy; (iii) such holders must have offered and, if requested, provide to the trustee security or indemnity satisfactory to the trustee
against any loss, liability or expense, (iv) the trustee does not comply with the request within a specified number of days after receipt
of the request and the offer, and if requested, the provision or security or indemnity; and (v) during such period the holders of a majority
in aggregate principal amount of the then-outstanding debt securities of such series do not give the trustee a direction inconsistent
with that request. However, holders of debt securities will have an absolute and unconditional right to receive payment of the principal
of, premium, if any, and interest, if any, thereon on the due dates expressed therein and to institute a suit for the enforcement of that
payment.
Satisfaction and Discharge of Indenture
The Indenture will cease to
be of further effect with respect to any series of debt securities (except as to certain limited surviving rights), when
| (1) | all securities of such series that have been authenticated and delivered (except lost, stolen or destroyed
securities that have been replaced or paid and securities for whose payment money has been deposited in trust and thereafter repaid to
the Company), have been delivered to the trustee for cancellation; or |
| (2) | all securities of such series that have not been delivered to the trustee for cancellation have become
due and payable or will become due and payable within one year, and we have irrevocably deposited or caused to be deposited with the trustee
the requisite amounts to pay and discharge the entire indebtedness on such securities; |
| (b) | no default or event of default has occurred and is continuing
on the date of such deposit (other than a default or event of default resulting from the borrowing of funds to be applied to such deposit)
and the deposit will not result in a breach or violation of, or constitute a default under, any other material instrument to which we
are, or any guarantor is, as applicable, a party or by which we are, or any guarantor is, as applicable, bound; |
| (c) | we have or any guarantor of such Notes has paid or caused to
be paid all applicable sums payable under this Indenture; |
| (d) | we have delivered irrevocable instructions to the trustee to
apply the deposited money toward the payment of the securities of such series at maturity or on the redemption date, as the case may
be; and |
| (e) | we have delivered to the trustee an officer's certificate and an opinion of counsel, each stating that
all conditions precedent relating to the satisfaction and discharge of the Indenture as to such series have been complied with. |
Amendment, Supplement and Waiver
We and the trustee may amend
and/or supplement the Indenture with the consent of the holders of a majority in aggregate principal amount of the outstanding debt securities
of each series affected. However, without the consent of each holder affected, an amendment or waiver (described below) may not, with
respect to any debt securities held by a non-consenting holder:
| · | reduce the principal amount, any premium or change the stated maturity of any debt security or alter or
waive any of the provisions with respect to the redemption or repurchase of such debt security; |
| · | reduce the rate (or alter the method of computation) of or extend the time for payment of interest, including
defaulted interest, on any debt security; |
| · | waive a default or event of default in the payment of principal of or premium, if any, or interest on
such debt securities, except a rescission of acceleration of such securities by the holders of at least a majority in aggregate principal
amount of the then outstanding securities of the applicable series with respect to a nonpayment default and a waiver of the payment default
that resulted from such acceleration; |
| · | make the principal of or premium, if any or interest on any debt security payable in currency other than
that stated therein; |
| · | change any place of payment where the debt securities or interest thereon is payable; |
| · | adversely affect any right to convert or exchange any debt security; |
| · | make any change in the provisions of the Indenture relating to waivers of past defaults or the rights
of holders of the debt securities to receive payments of principal of, premium, or interest, if any, thereon and/or to institute suit
for the enforcement of any such payments; |
| · | change any obligation of the Company to pay specified additional amounts; |
| · | make any change in the foregoing amendment and waiver provisions; or |
| · | reduce the percentage in principal amount of any debt securities, the consent of the holders of which
is required for any of the foregoing modifications or otherwise necessary to modify or amend the Indenture or to waive any past defaults. |
Subject to the restrictions
set forth above, the holders of a majority in aggregate principal amount of the outstanding debt securities of a series may, on behalf
of the holders of all debt securities of that series, waive compliance by us with any provision of the Indenture or the debt securities
with respect to such series.
The holders of a majority
in aggregate principal amount of the outstanding debt securities of a series may, on behalf of the holders of all debt securities of that
series, generally waive any past default under the Indenture and the consequences of such default. However, a default in respect of a
covenant or provision of the Indenture that cannot be modified or amended without the consent of the holder of each outstanding debt security
affected, or a default in the payment of the principal of, or premium, if any, or any interest on, any debt security, cannot be so waived.
Merger, Consolidation or Transfer of Assets
We will not consolidate or
amalgamate with or merge into or enter into any statutory arrangement with any other person or entity or sell, convey, transfer, lease
or otherwise dispose of all or substantially all of our and our subsidiaries' properties and assets, taken as a whole (a "Transfer"),
to any person or entity, unless:
| (a) | the entity formed by such consolidation or amalgamation or into
which we are merged, or to which such Transfer is made: (i) is a corporation, limited liability company, partnership, trust or other
entity organized and existing under the laws of Canada or any province or territory thereof, the United States, any state thereof or
the District of Columbia; and (ii) expressly assumes all of our obligations under the outstanding debt securities and the Indenture,
pursuant to a supplemental Indenture in form reasonably satisfactory to the trustee; |
| (b) | immediately after giving effect to such transaction,
no default or event of default under the Indenture shall have occurred and be continuing; and |
| (c) | we (or the surviving entity) shall have delivered to the trustee an officer's certificate and an opinion
of counsel, each stating that all conditions precedent relating to such transaction have been complied with. |
The requirements of paragraphs
(a) and (b) above do not apply to (1) any merger, amalgamation or consolidation in which we are the surviving corporation or (2) any Transfer
by us to a direct or indirect wholly owned subsidiary that is a guarantor or obligor of the debt securities.
Certain Covenants with respect to Canadian Taxes
If specified pursuant to the
Indenture, all payments made by us under or with respect to the securities of any series will be made free and clear of and without withholding
or deduction for or on account of any present or future tax, duty, levy, impost, assessment or other governmental charge (including penalties,
interest and other liabilities related thereto) imposed or levied by or on behalf of the Government of Canada or of any province or territory
thereof or by any authority or agency therein or thereof having power to tax ("Canadian Taxes"), unless we are required to withhold
or deduct Canadian Taxes by law or by the interpretation or administration thereof by the relevant governmental authority or agency. If
we are so required to withhold or deduct any amount for or on account of Canadian Taxes from any payment made under or with respect to
the securities, we will pay such additional amounts as may be necessary so that the net amount received by each holder (including additional
amounts) after such withholding or deduction will not be less than the amount the holder would have received if such Canadian Taxes had
not been withheld or deducted (a similar payment will also be made to holders that are exempt from withholding but are required to pay
tax directly on amounts otherwise subject to withholding); provided that no additional amounts will be payable:
| (1) | where such taxes are required to be withheld or deducted as
a result of such person or entity not dealing at arm's length with us (within the meaning of the Income Tax Act (Canada)) at the time
of the making of such payment; |
| (2) | where such taxes are required to be withheld or deducted as
a result of such person or entity being, or not dealing at arm's length with, a "specified shareholder" of the Company (within
the meaning of the Income Tax Act (Canada)); |
| (3) | to any person or entity by reason of their being connected with
Canada (otherwise than merely by holding or ownership of any series of securities or receiving any payments or exercising any rights
thereunder), including without limitation a nonresident insurer who carries on an insurance business in Canada and in a country other
than Canada; |
| (4) | for or on account of any tax, assessment or other governmental
charge which would not have been so imposed but for the presentation by the holder of such security or coupon for payment on a date more
than 10 days after the date on which such payment became due and payable or the date on which payment thereof is duly provided for, whichever
occurs later; |
| (5) | for or on account of any estate, inheritance, gift, sales, transfer,
personal property tax or any similar tax, assessment or other governmental charge; |
| (6) | for or on account of any tax, assessment or other governmental
charge required to be withheld by any paying agent from any payment to a person or entity in respect of any security, if such payment
can be made without such withholding by at least one other paying agent the identity of which is provided to such person or entity; |
| (7) | for or on account of any tax, assessment or other governmental
charge which is payable otherwise than by withholding from a payment in respect of such security; |
| (8) | to any person or entity which is subject to such Canadian Taxes
by reason of its failure to comply with any certification, identification, information, documentation or other reporting requirement
if compliance is required by law, regulation, administrative practice or an applicable treaty as a precondition to (or to reasonably
evidence) exemption from, or a reduction in the rate of deduction or withholding of, such Canadian Taxes; or |
| (9) | for any combination of items (1) - (8) above; |
nor will additional amounts be paid with respect
to any payment on a security to a holder who is a fiduciary or partnership or other than the sole beneficial owner of such payment to
the extent such payment would be required by the laws of Canada (or any political subdivision thereof) to be included in the income for
Canadian federal income tax purposes of a beneficiary or settlor with respect to such fiduciary or a member of such partnership or a beneficial
owner who would not have been entitled to payment of the additional amounts had such beneficiary, settlor, member or beneficial owner
been the holder of such security.
Defeasance and Covenant Defeasance
We may discharge all of our
obligations with respect to any series of debt securities at any time, and we may also be released from our obligations under certain
covenants and from certain other obligations, and elect not to comply with those covenants and obligations without creating an event of
default. Discharge under the first procedure is called "defeasance" and under the second procedure is called "covenant
defeasance."
Defeasance or covenant defeasance
may be effected only if:
| (1) | We irrevocably deposit with the trustee: an amount (in the currency
in which such securities are then specified as payable at maturity); specified government obligations; or a combination thereof, sufficient,
in the written opinion of a nationally recognized investment bank, appraisal firm, or firm of independent public accountants delivered
to the trustee, to pay the principal of (and premium, if any) and interest, if any, on the applicable securities at maturity (or redemption
date, if applicable); |
| (2) | No default or event of default shall have occurred and be continuing
on the date of such deposit; |
| (3) | Such defeasance or covenant defeasance shall not result in a
breach or violation of, or constitute a default under any material agreement or instrument (other than the Indenture) to which we are
a party or are bound; |
| (4) | In the case of a defeasance election by us, we shall have delivered
to the trustee an opinion of counsel stating that (x) we have received from, or there has been published by, the U.S. Internal Revenue
Service a ruling, or (y) since the date of execution of the Indenture, there has been a change in the applicable U.S. federal income
tax law, in either case to the effect that, and based thereon such opinion of counsel will confirm that, the beneficial owners of such
securities will not recognize income, gain or loss for U.S. federal income tax purposes as a result of such defeasance and will be subject
to U.S. federal income tax on the same amounts, in the same manner and at the same times as would have been the case if such defeasance
had not occurred; |
| (5) | In the case of a covenant defeasance election by us, we shall
have delivered to the trustee an opinion of counsel confirming that the beneficial owners of such securities will not recognize income,
gain or loss for U.S. federal income tax purposes as a result of such covenant defeasance and will be subject to U.S. federal income
tax on the same amounts, in the same manner and at the same times as would have been the case if such covenant defeasance had not occurred; |
| (6) | We have delivered to the trustee either an opinion of Canadian
counsel or a ruling from the Canada Revenue Agency, in either case to the effect that the holders of such securities will not recognize
income, gain or loss for Canadian federal, provincial or territorial income tax or other tax purposes as a result of such defeasance
or covenant defeasance and will be subject to Canadian federal or provincial income tax and other tax on the same amounts, in the same
manner and at the same times as would have been the case had such defeasance or covenant defeasance not occurred (and for the purposes
of such opinion of counsel, such Canadian counsel shall assume that holders include holders who are not resident in Canada); |
| (7) | We have delivered to the trustee an officer's certificate stating
that the deposit was not made by us with the intent of preferring the holders of such debt securities over our other creditors with the
intent of defeating, delaying or defrauding any creditors of the Company or others; |
| (8) | We are not an "insolvent person" within the meaning
of the Bankruptcy and Insolvency Act (Canada) on the date of such deposit or at any time during a specified period after the date of
such deposit (it being understood that this condition shall not be deemed satisfied until the expiration of such period); and |
| (9) | We shall have delivered to the trustee an officer's certificate and an opinion of counsel, each stating
that all conditions precedent relating to either the defeasance or the covenant defeasance have been complied with. |
Governing Law
The Indenture and the debt
securities shall be governed by and construed in accordance with the laws of the State of New York without regard to its principles of
conflict of laws. The Indenture is subject to the provisions of the Trust Indenture Act that are required to be a part of the Indenture
and shall, to the extent applicable, be governed by such provisions.
Concerning the Trustee
The trustee will have all
the duties and responsibilities of an indenture trustee specified in the Trust Indenture Act with respect to any debt securities issued
under the Indenture. The trustee will not be required to expend or risk its own funds or otherwise incur financial liability in performing
its duties or exercising its rights and powers if it reasonably believes that it is not reasonably assured of repayment or adequate indemnity.
Description of Warrants
We may issue warrants in one
or more series to purchase common shares, preferred shares, debt securities or other securities under this prospectus. Warrants may be
issued independently or together with any other securities and may be attached to, or separate from, such securities. Each series of warrants
will be issued under a separate warrant agreement to be entered into between us and a warrant agent. The terms of any warrants to be issued
and a description of the material provisions of the applicable warrant agreement will be set forth in the applicable prospectus supplement.
We expect that such terms will include, among others:
| · | the title of such warrants; |
| · | the aggregate number of such warrants; |
| · | the price or prices at which such warrants will be issued; |
| · | the number and type of securities purchasable upon exercise of such warrants; |
| · | the price at which our securities purchasable upon exercise of such warrants may be purchased; |
| · | the date on which the right to exercise such warrants shall commence and the date on which such right
shall expire; |
| · | if applicable, the minimum or maximum amount of such warrants which may be exercised at any one time; |
| · | if applicable, the designation and terms of the securities with which such warrants are issued and the
number of such warrants issued with each such security; |
| · | if applicable, the date on and after which such warrants and the related securities will be separately
transferable; |
| · | information with respect to book-entry procedures, if any; |
| · | if applicable, a discussion of any material U.S. federal or Canadian income tax considerations; and |
| · | any other terms of such warrants, including terms, procedures and limitations relating to the exchange
and exercise of such warrants. |
PLAN OF DISTRIBUTION
We or any selling shareholder
may sell the securities described in this prospectus in any one or more of the following ways from time to time: (i) through agents; (ii)
to or through underwriters, including through underwriting syndicates represented by managing underwriters; (iii) through brokers or dealers;
(iv) directly by us to purchasers pursuant to applicable statutory exemptions; or (v) through a combination of any of these methods of
sale. We will set forth in an applicable prospectus supplement a description of the specific types of securities that may be offered under
this prospectus. The terms of the offering of securities, the initial offering price and the net proceeds to us will be contained in the
prospectus supplement and other offering material relating to such offer. The prospectus supplement may also add, update or change information
contained in this prospectus, and/or describe certain risks in addition to those referred to herein associated with an investment in the
specific securities offered. You should carefully read this prospectus and any applicable prospectus supplement before you invest in any
of our securities.
By Agents
We may designate agents who
agree to use their reasonable efforts to solicit purchases for the period of their appointment or to sell securities on a continuing basis.
Any agent involved will be named, and any commissions payable by us to such agent will be set forth, in the applicable prospectus supplement.
By Underwriters or Dealers
If underwriters are used in
the sale, the securities will be acquired by the underwriters for their own account and may be resold from time to time in one or more
transactions, including negotiated transactions, at a fixed public offering price or at varying prices determined at the time of sale.
The underwriter or underwriters with respect to a particular underwritten offering of securities, or, if an underwriting syndicate is
used, the managing underwriter or underwriters, will be set forth on the cover of the applicable prospectus supplement. Unless otherwise
set forth in the prospectus supplement relating thereto, the obligations of the underwriters to purchase the securities will be subject
to certain conditions and the underwriters will be obligated to purchase all of the securities if any are purchased. We may change from
time to time any initial public offering price and any discounts or concessions the underwriters allow or re-allow or pay to dealers.
We may use underwriters with whom we have a material relationship. We will describe in the prospectus supplement naming the underwriter
the nature of any such relationship.
We may grant to the underwriters
an option to purchase additional offered securities, to cover over-allotments, if any, at the public offering price (with additional underwriting
discounts or commissions), as may be set forth in the related prospectus supplement, or if applicable, the pricing supplement. If we grant
any over-allotment options, the terms of the over-allotment option will be set forth in the prospectus supplement relating to such offered
securities.
Until the distribution of
the securities is completed, rules of the Commission may limit the ability of underwriters and other participants in the offering to bid
for and purchase the securities. As an exception to these rules, the underwriters in certain circumstances are permitted to engage in
certain transactions that stabilize the price of the securities. Such transactions consist of bids or purchases for the purpose of pegging,
fixing or maintaining the price of the securities. If the underwriters create a short position in the securities in connection with the
offering by selling more securities than are set forth on the cover page of the applicable prospectus supplement or in the term sheet,
the underwriters may reduce that short position by purchasing securities in the open market. The underwriters also may impose a penalty
bid on certain underwriters. This means that if the underwriters purchase the securities in the open market to reduce the underwriters'
short position or to stabilize the price of the securities, they may reclaim the amount of the selling concession from the underwriters
who sold those securities as part of the offering. In general, purchases of a security for the purpose of stabilization or to reduce a
short position could cause the price of the security to be higher than it might be in the absence of such purchases. The imposition of
a penalty bid might also have an effect on the price of a security to the extent that it were to discourage resales of the security.
If dealers are used and, if
so, specified in the applicable prospectus supplement, we will sell such securities to the dealers as principals. The dealers may then
resell such securities to the public or other dealers at fixed or varying prices to be determined by such dealers at the time of resale.
The names of the dealers and the terms of any such transaction will be set forth in the applicable prospectus supplement.
Direct Sales
Securities may also be sold
directly by us. In this case, no underwriters, dealers or agents would be involved. Except as set forth in the related prospectus supplement,
none of our directors, officers or employees will solicit or receive a commission in connection with those direct sales. Those persons
may respond to inquiries by potential purchasers and perform ministerial and clerical work in connection with direct sales.
Delayed Delivery Contracts
We may authorize underwriters,
dealers and agents to solicit offers by certain institutions to purchase securities pursuant to delayed delivery contracts providing for
payment and delivery on a future date specified in the applicable prospectus supplement. Institutions with which delayed delivery contracts
may be made include commercial and savings banks, insurance companies, educational and charitable institutions and other institutions
we may approve. The obligations of any purchaser under any delayed delivery contract will not be subject to any conditions except that
any related sale of offered securities to underwriters shall have occurred and the purchase by an institution of the securities covered
by its delayed delivery contract shall not at the time of delivery be prohibited under the laws of any jurisdiction in the United States
to which that institution is subject. Any commission paid to underwriters, dealers and agents soliciting purchases of securities pursuant
to delayed delivery contracts accepted by us will be detailed in a prospectus supplement.
Selling Shareholders
Any selling shareholder may
offer common shares using any of the methods described above, through agents, underwriters, dealers or in direct sales or delayed delivery
contracts. The applicable prospectus supplement will describe the selling shareholder's method of distribution, will name any agent, underwriter
or dealer of the selling shareholder and will describe the compensation to be paid to any of these parties. In addition to distribution
as outlined above, any selling shareholders may sell their common shares pursuant to Rule 144 under the Securities Act, if applicable
and available, or any other available exemption from registration under the Securities Act.
General Information
We may enter into agreements
with underwriters, dealers and agents that entitle them to indemnification against certain civil liabilities, including liabilities under
the Securities Act, or to contribution with respect to payments which the underwriters, dealers or agents may be required to make. Underwriters,
dealers and agents may be customers of, may engage in transactions with, or perform services for, us or our subsidiaries in the ordinary
course of business.
Underwriters, dealers and
agents that participate in the distribution of the securities may be underwriters as defined in the Securities Act, and any discounts
or commissions received by them from us and any profit on the resale of the securities by them may be treated as underwriting discounts
and commissions under the Securities Act. Any underwriters, dealers or agents used in the offer or sale of securities will be identified
and their compensation described in an applicable prospectus supplement.
Unless we state otherwise
in a prospectus supplement, we will bear the costs relating to the securities being registered under this Registration Statement.
MATERIAL INCOME TAX CONSIDERATIONS
Information regarding material
Canadian and U.S. federal income tax consequences to persons investing in the securities offered by this prospectus will be set forth
in an applicable prospectus supplement. You should consult your own tax advisors prior to any acquisition of our securities.
INCORPORATION OF CERTAIN INFORMATION BY
REFERENCE
We incorporate by reference
into this prospectus the following documents we have filed with the Commission:
| · | the Company's Annual Report on Form 10-K for the year ended December 31, 2024 filed with the Commission on March 3, 2025; |
| · | the description of the Company's common shares contained in its Registration Statement on Form 8-A/A,
filed with the Commission on April 25, 2024. |
All documents subsequently
filed by the Company pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act after the date of this Registration Statement
and prior to the filing of a post-effective amendment which indicates that all securities offered hereby have been sold or which deregisters
all securities then remaining unsold, shall be deemed to be incorporated by reference into this Registration Statement and to be a part
hereof from the date of filing of such documents. The Company will not, however, incorporate by reference in this Registration Statement
any documents or portions thereof that are not deemed "filed" with the Commission, including any information furnished by the
Company pursuant to Item 2.02 or Item 7.01 of its Current Reports on Form 8-K unless, and except to the extent, specified in such
reports.
Any statement contained in
any document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded for purposes of
this prospectus to the extent that a statement contained herein or in any other subsequently filed or furnished document which also is
or is deemed to be incorporated by reference herein modifies or supersedes such statement. Any such statement so modified or superseded
shall not be deemed to constitute a part of this prospectus, except as so modified or superseded.
Upon written or oral request,
we will provide to each person, including any beneficial owner, to whom this prospectus is delivered, a copy of any or all of the information
that is incorporated by reference into this prospectus but not delivered with this prospectus (other than exhibits to those documents
unless such exhibits are specially incorporated by reference in those documents), at no cost, by writing to or telephoning us at the following
address:
Celestica Inc.
5140 Yonge Street, Suite 1900
Toronto, Ontario
Canada M2N 6L7
416-448-5800
Attention: Investor Relations
WHERE YOU CAN FIND MORE INFORMATION
We file annual, quarterly
and current reports, proxy statements and other information with the Commission, including the Registration Statement of which this prospectus
forms a part. The Commission maintains an internet site (http://www.sec.gov) that contains reports, proxy and information statements
and other information regarding issuers that file electronically with the Commission.
We also file reports, statements
and other information with the Canadian Securities Administrators (the "CSA") and these can be accessed electronically at the
CSA's System for Electronic Document Analysis and Retrieval website (http://www.sedarplus.ca).
You may access other information
about Celestica on our website (http://www.celestica.com). Information on our website is not incorporated by reference into this prospectus.
This prospectus, which constitutes
a part of the Registration Statement, does not contain all of the information set forth in the Registration Statement or the exhibits
and schedules filed with it. For further information about us, our securities and other information set forth herein, reference is made
to the Registration Statement and exhibits and schedules filed with it. Statements contained in this prospectus regarding the contents
of any contract or any other document that is filed as an exhibit to the Registration Statement are not necessarily complete, and each
such statement is subject to, and qualified in its entirety by, reference to the applicable contract or other document filed herewith.
LEGAL MATTERS
The validity of the securities
in respect of which this prospectus is being delivered will be passed upon for us by Blake, Cassels & Graydon LLP with respect to
matters of Canadian law, and Skadden, Arps, Slate, Meagher & Flom LLP with respect to matters of New York and U.S. federal law.
ENFORCEABILITY OF CIVIL LIABILITIES
We are incorporated under
the laws of the Province of Ontario, Canada. Certain experts named in this prospectus, and some of our directors and executive officers
are residents of Canada. Also, a substantial portion of our assets and the assets of these persons are located outside of the United States.
As a result, securityholders may find it difficult to effect service of process within the United States upon these persons who are not
residents of the United States, or to enforce judgments in the United States obtained in courts of the United States, because a significant
portion of our assets and the assets of these persons are located outside the United States. It may also be difficult for securityholders
to enforce a United States judgment in Canada based on the civil liability provisions of the United States federal securities laws or
the "blue sky" laws of any state within the United States or to succeed in a lawsuit in Canada based only on United States federal
or state securities laws.
EXPERTS
Our consolidated financial
statements as of December 31, 2023 and 2024, and for each of the years in the three-year period ended December 31, 2024, incorporated
in this prospectus by reference to our Annual Report on Form 10-K for the year ended December 31, 2024, and the effectiveness of our internal
control over financial reporting as of December 31, 2024, have been audited by KPMG LLP, an independent registered public accounting firm,
as set forth in their reports thereon included therein, and incorporated herein by reference. Such consolidated financial statements are
incorporated herein in reliance upon the reports of KPMG LLP pertaining to such consolidated financial statements and the effectiveness
of our internal control over financial reporting, upon the authority of said firm as experts in auditing and accounting.
CELESTICA INC.
COMMON SHARES
PREFERRED SHARES
DEBT SECURITIES
WARRANTS
PROSPECTUS
March 3, 2025
PART II
INFORMATION NOT REQUIRED IN PROSPECTUS
| ITEM 14. | Other Expenses of Issuance and Distribution |
The following is a statement
of the estimated expenses, other than any underwriting discounts and commissions, that we expect to incur in connection with the issuance
and distribution of the securities registered under this registration statement:
| Commission registration fee |
|
$ |
|
* |
| Printing expenses |
|
|
|
** |
| Legal fees and expenses |
|
|
|
** |
| Accountants' fees and expenses |
|
|
|
** |
| Transfer agent and registrar fees |
|
|
|
** |
| Trustee fees |
|
|
|
** |
| Miscellaneous |
|
|
|
** |
| Total |
|
$ |
|
** |
| * |
$648,111.04 has been paid to the Commission and may be used to pay for securities offered pursuant to this prospectus. The payment of any additional fees has been deferred in accordance with Rule 456(b) and 457(r) of the Securities Act. |
| ** |
Information regarding offering expenses is not currently known. The foregoing sets forth the general categories of expenses (other than underwriting discounts and commissions) that the Company anticipates it will incur in connection with the offering of securities under this Registration Statement. An estimate of the aggregate expenses in connection with the issuance and distribution of the securities being offered will be included in any applicable prospectus supplement. |
ITEM 15. INDEMNIFICATION OF DIRECTORS AND OFFICERS
Under the OBCA, the registrant
may indemnify a present or former director or officer or a person who acts or acted at the registrant's request as a director or officer,
or an individual acting in a similar capacity, of another entity, against all costs, charges and expenses, including an amount paid to
settle an action or satisfy a judgment, reasonably incurred by that individual in respect of any civil, criminal, administrative, investigative
or other proceeding in which the individual is involved because of that association with the registrant or other entity; provided that
the individual acted honestly and in good faith with a view to the best interests of the registrant or, as the case may be, to the best
interests of such other entity and, in the case of a criminal or administrative action or proceeding that is enforced by a monetary penalty,
had reasonable grounds for believing that the individual's conduct was lawful. Such indemnification may be made in connection with a derivative
action only with court approval. An individual is entitled to indemnification from the registrant as a matter of right if the individual
was not judged by a court or other competent authority to have committed any fault or omitted to do anything that the individual ought
to have done and the individual fulfilled the conditions set forth above. Under such Act, the registrant may advance money to a director,
officer or other individual for the costs, charges and expenses of a proceeding referred to above, but the individual must repay the money
if the individual does not fulfil the conditions set forth above.
In accordance with and subject
to the OBCA, the by-laws of the registrant provide for indemnification of a director or officer of the registrant, a former director or
officer of the registrant, or a person who acts or acted at the registrant's request as a director or officer, or an individual acting
in a similar capacity, of another entity, and his heirs and legal representatives, against all costs, charges and expenses, including
an amount paid to settle an action or satisfy a judgment, reasonably incurred by him in respect of any civil, criminal, administrative,
investigative or other proceeding in which the individual is involved because of that association with the registrant or other entity,
if he acted honestly and in good faith with a view to the best interests of the registrant or, as the case may be, to the best interests
of the other entity for which he acted as a director or officer or in a similar capacity at the registrant's request. Also, the by-laws
provide that the registrant may advance money to a director, officer or other person for the costs, charges and expenses of a proceeding
referred to above, but the person shall repay the money if the person does not fulfil the conditions set forth above.
The directors and officers
of the registrant are covered by directors' and officers' insurance policies.
Reference is made to Item
17 for the undertakings of the registrant with respect to indemnification for liabilities arising under the Securities Act.
ITEM 16. EXHIBITS
(a) EXHIBITS:
The following exhibits have been filed as part
of this registration statement:
EXHIBIT
NUMBER |
|
DESCRIPTION |
| 1.1* |
|
Form of Underwriting Agreement |
| 4.1 |
|
Form
of Common Share Certificate (1) |
| 4.2 |
|
Certificate and Restated Articles of Incorporation effective April 25, 2024 (1) |
| 4.3 |
|
Certificate and Articles of Amendment, effective April 25, 2024 (1) |
| 4.4 |
|
Amended
and Restated By-law 1 (2) |
| 4.5 |
|
By-law No. 2 (3) |
| 4.6* |
|
Form of Preferred Share Certificate |
| 4.7* |
|
Form of Warrant |
| 4.8 |
|
Form of Indenture (4) |
| 5.1 |
|
Opinion of Blake, Cassels & Graydon LLP |
| 5.2 |
|
Opinion of Skadden, Arps, Slate, Meagher & Flom LLP |
| 23.1 |
|
Consent of KPMG LLP, Chartered Professional Accountants, Licensed Public Accountants |
| 23.2 |
|
Consent of Blake, Cassels & Graydon LLP (contained in opinion filed as Exhibit 5.1) |
| 23.3 |
|
Consent of Skadden, Arps, Slate, Meagher & Flom LLP (contained in opinion filed as Exhibit 5.2) |
| 24.1 |
|
Powers of Attorney (included in signature page hereto) |
| 25.1** |
|
T-1 Statement of Eligibility and Qualification of Trustee |
| 107 |
|
Filing Fee Table |
| |
* |
To be filed by amendment or by a Current Report on Form 8-K incorporated herein by reference. |
| |
** |
To be filed in accordance with the requirements of Section 305(b)(2) of the Trust Indenture Act of 1939 and Rule 5b-3 thereunder. |
| (1) |
Incorporated by reference to the Registrant's Report on Form 6-K (File No. 001-14832) furnished to the Commission on April 25, 2024. |
| |
|
| (2) |
Incorporated by reference to Registrant's Report on Form 6-K (File No. 001-14832) furnished to the Commission on February 28, 2024. |
| |
|
| (3) |
Incorporated by reference to Registrant's Report on Form 8-K (File No. 001-14832) filed with the Commission on January 31, 2025. |
| |
|
| (4) |
Incorporated by reference to Registration Statement on Form F-3 (File No. 333-221144) filed on October 26, 2017. |
ITEM 17. UNDERTAKINGS
(a)
The undersigned registrant hereby undertakes:
| (1) | To file, during any period in which offers or sales are being made, a post-effective amendment to this
registration statement: |
| i. | to include any prospectus required by Section 10(a)(3) of the
Securities Act; |
| ii. | to reflect in the prospectus any facts or events arising after
the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the
aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing,
any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which
was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus
filed with the Commission pursuant to Rule 424(b), if, in the aggregate, the changes in volume and price represent no more than a 20%
change in the maximum aggregate offering price set forth in the "Calculation of Filing Fee Tables" or "Calculation of
Registration Fee" table, as applicable, in the effective registration statement; and |
| iii. | to include any material information with respect to the plan of distribution not previously disclosed
in the registration statement or any material change to such information in the registration statement; |
provided,
however, that paragraphs (a)(1)(i), (a)(1)(ii) and (a)(1)(iii) above do not apply if the information required to be included
in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the Commission by the registrant
pursuant to section 13 or section 15(d) of the Securities Exchange Act of 1934 that are incorporated by reference in the registration
statement, or is contained in a form of prospectus filed pursuant to Rule 424(b) that is part of the registration statement.
| (2) | That, for the purpose of determining any liability under the Securities Act of 1933, each such post-effective
amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities
at that time shall be deemed to be the initial bona fide offering thereof. |
| (3) | To remove from registration by means of a post-effective amendment any of the securities being registered
which remain unsold at the termination of the offering. |
| (5) | That, for the purpose of determining liability under the Securities Act of 1933 to any purchaser: |
| i. | Each prospectus filed by the registrant pursuant to Rule 424(b)(3)
shall be deemed to be part of the registration statement as of the date the filed prospectus was deemed part of and included in the registration
statement; and |
| ii. | Each prospectus required to be filed pursuant to Rule 424(b)(2),
(b)(5) or (b)(7) as part of a registration statement in reliance on Rule 430B relating to an offering made pursuant to Rule 415(a)(1)(i),
(vii), or (x) for the purpose of providing the information required by section 10(a) of the Securities Act of 1933 shall be deemed to
be part of and included in the registration statement as of the earlier of the date such form of prospectus is first used after effectiveness
or the date of the first contract of sale of securities in the offering described in the prospectus. As provided in Rule 430B, for liability
purposes of the issuer and any person that is at that date an underwriter, such date shall be deemed to be a new effective date of the
registration statement relating to the securities in the registration statement to which that prospectus relates, and the offering of
such securities at that time shall be deemed to be the initial bona fide offering thereof. Provided, however, that no statement
made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed
incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser
with a time of contract of sale prior to such effective date, supersede or modify any statement that was made in the registration statement
or prospectus that was part of the registration statement or made in any such document immediately prior to such effective date. |
| (6) | That, for the purpose of determining liability of the registrant under the Securities Act of 1933 to any
purchaser in the initial distribution of the securities, the undersigned registrant undertakes that in a primary offering of securities
of the undersigned registrant pursuant to this registration statement, regardless of the underwriting method used to sell the securities
to the purchaser, if the securities are offered or sold to such purchaser by means of any of the following communications, the undersigned
registrant will be a seller to the purchaser and will be considered to offer or sell such securities to such purchaser: |
(i) Any preliminary prospectus or prospectus
of the undersigned registrant relating to the offering required to be filed pursuant to Rule 424;
(ii) Any free writing prospectus relating
to the offering prepared by or on behalf of the undersigned registrant or used or referred to by the undersigned registrant;
(iii) The portion of any other free
writing prospectus relating to the offering containing material information about the undersigned registrant or its securities provided
by or on behalf of the undersigned registrant; and
(iv) Any other communication that is
an offer in the offering made by the undersigned registrant to the purchaser.
| (b) | The undersigned registrant hereby undertakes that, for purposes
of determining any liability under the Securities Act of 1933, each filing of the registrant's annual report pursuant to section 13(a)
or section 15(d) of the Securities Exchange Act of 1934 (and, where applicable, each filing of an employee benefit plan's annual report
pursuant to section 15(d) of the Securities Exchange Act of 1934) that is incorporated by reference in the registration statement shall
be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that
time shall be deemed to be the initial bona fide offering thereof. |
(c) – (g) N/A
| (h) | Insofar as indemnification for liabilities arising under the
Securities Act of 1933 may be permitted to directors, officers and controlling persons of the registrant pursuant to the foregoing provisions,
or otherwise, the registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against
public policy as expressed in the Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities
(other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant
in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection
with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling
precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as
expressed in the Act and will be governed by the final adjudication of such issue. |
| (j) | The undersigned registrant hereby undertakes to file an application
for the purpose of determining the eligibility of the trustee to act under subsection (a) of section 310 of the Trust Indenture Act ("Act")
in accordance with the rules and regulations prescribed by the Commission under section 305(b)(2) of the Act. |
SIGNATURES
Pursuant to the requirements
of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements
for filing on Form S-3 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized,
in the City of Burlington, Province of Ontario, Country of Canada, on the 3rd day of March, 2025.
| |
CELESTICA INC. |
| |
|
|
| |
By: |
/s/ Douglas Parker |
| |
|
Douglas Parker |
| |
|
Chief Legal Officer and Corporate Secretary |
POWER OF ATTORNEY
Each person whose signature
appears below hereby authorizes and appoints Robert A. Mionis, Mandeep Chawla and/or Douglas Parker and each of them, any of whom may
act without the joinder of any other, as his or her true and lawful attorney-in-fact and agent, with full power of substitution and re-substitution,
for him or her and in his or her name, place and stead, to sign and file on his or her behalf, individually and in any capacity, any amendments
and post-effective amendments to this registration statement, with exhibits thereto, and all other documents in connection therewith,
including registration statements filed in connection with this offering pursuant to Rule 462(b) under the Securities Act, with the Commission,
granting unto said attorneys-in-fact and agents full power and authority to do everything necessary to accomplish the foregoing, as fully
to all intents and purposes as he or she might or could do in person, and each of the undersigned does hereby ratify and confirm all that
each of said attorneys-in-fact and agents, or their substitutes, shall do or cause to be done by virtue hereof.
Pursuant to the requirements
of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates
indicated.
| SIGNATURE |
|
TITLE |
|
DATE |
| |
|
|
|
|
| /s/ Robert A. Mionis |
|
Director, President and Chief Executive Officer |
|
March 3, 2025 |
| Robert A. Mionis |
|
(Principal Executive Officer) |
|
|
| |
|
|
|
|
| /s/ Mandeep Chawla |
|
Chief Financial Officer |
|
March 3, 2025 |
| Mandeep Chawla |
|
(Principal Financial Officer and Principal Accounting Officer) |
|
|
| |
|
|
|
|
| /s/ Michael M. Wilson |
|
Chair of the Board and Director |
|
March 3, 2025 |
| Michael M. Wilson |
|
|
|
|
| |
|
|
|
|
| /s/ Kulvinder (Kelly) Ahuja |
|
Director |
|
March 3, 2025 |
| Kulvinder (Kelly) Ahuja |
|
|
|
|
| |
|
|
|
|
| /s/ Robert A. Cascella |
|
Director |
|
March 3, 2025 |
| Robert A. Cascella |
|
|
|
|
| |
|
|
|
|
| /s/ Françoise Colpron |
|
Director |
|
March 3, 2025 |
| Françoise Colpron |
|
|
|
|
| |
|
|
|
|
| /s/ Jill Kale |
|
Director |
|
March 3, 2025 |
| Jill Kale |
|
|
|
|
| |
|
|
|
|
| /s/ Amar Maletira |
|
Director |
|
March 3, 2025 |
| Amar Maletira |
|
|
|
|
| |
|
|
|
|
| /s/ Luis A. Müller |
|
Director |
|
March 3, 2025 |
| Luis A. Müller |
|
|
|
|
| |
|
|
|
|
AUTHORIZED REPRESENTATIVE
Pursuant to the requirements
of Section 6(a) of the Securities Act, the undersigned has signed this Registration Statement, solely in the capacity of the duly authorized
representative of Celestica Inc. in the United States, on the 3rd day of March, 2025.
| |
Celestica Inc. |
| |
(Authorized U.S. Representative) |
| |
|
|
| |
By: |
/s/ Robert A. Mionis |
| |
|
Robert A. Mionis |
| |
|
President and Chief Executive Officer |
Exhibit 5.1
| March 3, 2025 |
| |
| Celestica Inc. |
| 5140 Yonge Street, Suite 1900 |
| Toronto, Ontario |
| Canada M2N 6L7 |
| Re: |
Celestica Inc. |
| |
Registration Statement on Form S-3 |
Dear Sirs/Mesdames:
We have acted as Canadian counsel to Celestica
Inc. (the “Company”) in connection with the Registration Statement on Form S-3 (the “Registration Statement”)
filed on March 3, 2025 by the Company with the U.S. Securities and Exchange Commission (the “Commission”) under the U.S.
Securities Act of 1933, as amended (the “Act”), relating to the registration by the Company for its issue and sale from time
to time of, among other securities, common shares (the “Common Shares”) and preference shares (the “Preference Shares”
and together with the Common Shares, the “Securities”) in its capital.
This opinion letter is being provided at the request
of the Company. As Canadian counsel for the Company, we have examined a copy of the Registration Statement.
We are solicitors qualified to practice law in
the Province of Ontario and the opinions expressed herein relate only to the laws of the Province of Ontario and the laws of Canada applicable
therein as in effect on the date hereof.
In connection with the opinions expressed in this
opinion letter, we have considered such questions of law, examined originals or copies of such statutes, regulations, documents, records,
certificates and instruments and conducted such other examinations as we have considered necessary. In such examinations, we have assumed
the legal capacity of all individuals, the genuineness of all signatures, the authenticity of all documents submitted to us as originals
and the conformity to authentic original documents of all documents submitted to us as certified, conformed, photostatic or facsimile
copies.
We have also assumed that at all relevant times:
| 1. |
the Company is validly existing under the Business Corporations Act (Ontario) and has the necessary corporate power and capacity to own its property and assets and to carry on its business; |
| 2. |
the Company has the necessary corporate power and capacity to execute, deliver and perform its obligations under the terms and conditions of any purchase, underwriting or other agreement, indenture or instrument relating to the Company’s creation, authentication, issuance, sale and/or delivery of the Securities to which the Company is party (any such agreement, the “Agreement”); |
| 3. |
the Company has the necessary corporate power and capacity to authorize, create, authenticate, validly issue, sell and deliver the Securities and perform its obligations under the terms and conditions of the Securities; |
| 4. |
all necessary corporate action has been taken by the Company to duly authorize the execution and delivery by the Company of the Agreement and the performance of its obligations under the terms and conditions thereof; |
 |
Page 2 |
| 5. |
all necessary corporate action has been taken by the Company to duly authorize, create, authenticate, sell, deliver and validly issue the Securities and to perform its obligations under the terms and conditions of the Securities; |
| 6. |
all necessary corporate action has been taken by the Company to duly authorize the terms of the offering of the Securities and related matters; |
| 7. |
the Agreement (i) has been duly authorized, executed and delivered by all parties thereto and such parties had the capacity to do so; (ii) constitutes a legal, valid and binding obligation of all parties thereto; and (iii) is enforceable in accordance with its terms against all parties thereto; |
| 8. |
the Securities have been duly authorized, created, authenticated, sold and delivered and validly issued by the Company and any other person signing or authenticating the Securities, as applicable; |
| 9. |
the terms of the offering of the Securities and related matters have been duly authorized by the Company; |
| 10. |
the execution and delivery of the Agreement and the performance by the Company of its obligations under the terms and conditions thereunder do not and will not conflict with and do not and will not result in a breach of or default under, and do not and will not create a state of facts which, after notice or lapse of time or both, will conflict with or result in a breach of or default under any of the terms or conditions of the articles or by-laws of the Company, any resolutions of the Board of Directors or shareholders of the Company, any agreement or obligation of the Company, or applicable law; |
| 11. |
the authorization, creation, authentication, sale, delivery and issuance of the Securities and the Company’s performance of its obligations under the terms and conditions of the Securities do not and will not conflict with and do not and will not result in a breach of or default under, and do not and will not create a state of facts which, after notice or lapse of time or both, will conflict with or result in a breach of or default under any of the terms or conditions of the articles or by-laws of the Company, any resolutions of the Board of Directors or shareholders of the Company, any agreement or obligation of the Company, or applicable law; and |
| 12. |
the terms of the offering of the Securities and related matters do not and will not conflict with and do not and will not result in a breach of or default under, and do not and will not create a state of facts which, after notice or lapse of time or both, will conflict with or result in a breach of or default under any of the terms or conditions of the articles or by-laws of the Company, any resolutions of the Board of Directors or shareholders of the Company, any agreement or obligation of the Company, or applicable law. |
Based upon the foregoing, and subject to the qualifications,
assumptions and limitations stated herein, we are of the opinion that, upon payment for the applicable Securities provided for in the
applicable Agreement and otherwise in accordance with such Agreement, the Securities will be validly issued, fully paid and non-assessable
shares in the capital of the Company.
We hereby consent to the filing of this opinion
letter as Exhibit 5.1 to the Registration Statement and to the use of our name under the caption “Legal Matters” in the
Prospectus included in the Registration Statement. In giving this opinion, we do not thereby admit that we are within the category of
persons whose consent is required under Section 7 of the U.S. Securities Act of 1933 or the rules and regulations of the U.S.
Securities and Exchange Commission thereunder.
Yours
very truly,
/s/ Blake, Cassels & Graydon LLP
Exhibit 5.2
| |
Skadden, Arps, Slate, Meagher &
Flom llp |
|
| |
One Manhattan West |
FIRM/AFFILIATE |
| |
New York, NY 10001 |
OFFICES |
| |
________ |
----------- |
| |
|
|
| |
TEL: (212) 735-3000 |
BOSTON |
| |
FAX: (212) 735-2000 |
CHICAGO |
| |
www.skadden.com |
HOUSTON |
| |
|
LOS ANGELES |
| |
|
PALO ALTO |
| |
|
WASHINGTON, D.C. |
| |
|
WILMINGTON |
| |
|
----------- |
| |
|
ABU DHABI |
| |
|
BEIJING |
| |
|
BRUSSELS |
| |
|
FRANKFURT |
| |
|
HONG KONG |
| |
|
LONDON |
| |
|
MUNICH |
| |
|
PARIS |
| |
|
SÃO PAULO |
| |
|
SEOUL |
| |
|
SINGAPORE |
| |
|
TOKYO |
| |
|
TORONTO |
March 3, 2025
Celestica Inc.
5140 Yonge Street, Suite 1900
Toronto, Ontario
Canada M2N 6L7
| Re: | Celestica Inc.
Registration Statement on Form S-3 |
Ladies and Gentlemen:
We have acted as special United States counsel to
Celestica Inc., a corporation organized under the laws of Ontario (the “Company”), in connection with the registration statement
on Form S-3 (the “Registration Statement”) to be filed on the date hereof by the Company with the Securities and Exchange
Commission (the “Commission”) under the Securities Act of 1933 (the “Securities Act”). The Registration Statement
relates to the issuance and sale by the Company from time to time, pursuant to Rule 415 of the General Rules and Regulations
of the Commission promulgated under the Securities Act (the “Rules and Regulations”), of debt securities of the Company
(“Debt Securities”), which may be issued in one or more series under an indenture (the “Indenture”) proposed
to be entered into by the Company and the trustee to be named therein, the form of which is filed as an exhibit to the Registration Statement,
and other securities of the Company.
This opinion is being furnished in accordance with
the requirements of Item 601(b)(5) of Regulation S-K under the Securities Act.
In rendering the opinion stated herein, we have
examined and relied upon the following:
(a) the
Registration Statement; and
(b) the
form of Indenture filed as an exhibit to the Registration Statement.
We have also examined originals or copies, certified
or otherwise identified to our satisfaction, of such records of the Company and such agreements, certificates and receipts of public
officials, certificates of officers or other representatives of the Company and others, and such other documents as we have deemed necessary
or appropriate as a basis for the opinion stated below.
Celestica Inc.
March 3, 2025
Page 2
In our examination, we have assumed the genuineness
of all signatures, including electronic signatures, the legal capacity and competency of all natural persons, the authenticity of all
documents submitted to us as originals, the conformity to original documents of all documents submitted to us as facsimile, electronic,
certified or photocopied copies, and the authenticity of the originals of such copies. As to any facts relevant to the opinion stated
herein that we did not independently establish or verify, we have relied upon statements and representations of officers and other representatives
of the Company and others and of public officials.
We do not express any opinion with respect to the
laws of any jurisdiction other than the laws of the State of New York (“Opined-on Law”). We do not express any opinion as
to the effect of any non-Opined-on Law on the opinion stated herein. The Debt Securities may be issued from time to time on a delayed
or continuous basis, and this opinion is limited to the laws, including the rules and regulations, as in effect on the date hereof,
which laws are subject to change with possible retroactive effect.
As used herein “Transaction Documents”
means the Indenture and the supplemental indentures thereto.
The opinion stated in paragraph 1 below presumes
that all of the following (collectively, the “general conditions”) shall have occurred prior to the issuance of any series
of Debt Securities referred to therein: (i) the Registration Statement, as finally amended (including all necessary post-effective
amendments), has become effective under the Securities Act; (ii) an appropriate prospectus supplement or term sheet with respect
to such Debt Securities has been prepared, delivered and filed in compliance with the Securities Act and the applicable Rules and
Regulations; (iii) the applicable Transaction Documents shall have been duly authorized, executed and delivered by the Company and
the other parties thereto, including, if such Debt Securities are to be sold or otherwise distributed pursuant to a firm commitment underwritten
offering, the underwriting agreement or purchase agreement with respect thereto; (iv) the Board of Directors of the Company, including
any duly authorized committee thereof, shall have taken all necessary corporate action to approve the issuance and sale of such Debt
Securities and related matters and appropriate officers of the Company have taken all related action as directed by or under the direction
of the Board of Directors of the Company; and (v) the terms of the applicable Transaction Documents and the issuance and sale of
such Debt Securities have been duly established in conformity with the articles of incorporation of the Company so as not to violate
any applicable law, the articles of incorporation of the Company or the bylaws of the Company, or result in a default under or breach
of any agreement or instrument binding upon the Company or its properties, and so as to comply with any requirement or restriction imposed
by any court or governmental body having jurisdiction over the Company or its properties.
Based upon the foregoing and subject to the qualifications
and assumptions stated herein, we are of the opinion that:
1. With
respect to any series of Debt Securities offered by the Company, including such indeterminate amount of Debt Securities as may be issued
upon conversion or exchange of such series (the “Offered Debt Securities”), when (a) the general conditions shall have
been satisfied, (b) the Indenture has been qualified under the Trust Indenture Act of 1939, (c) the issuance, sale and terms
of the Offered Debt Securities and related matters have been approved and established in conformity with the applicable Transaction Documents
and (d) the certificates evidencing the Offered Debt Securities have been issued in a form that complies with the provisions of
the applicable Transaction Documents and have been duly executed and authenticated in accordance with the provisions of the Indenture
and any other applicable Transaction Documents and issued and sold or otherwise distributed in accordance with the provisions of the
applicable Transaction Document upon payment of the agreed-upon consideration therefor, the Offered Debt Securities will constitute valid
and binding obligations of the Company, enforceable against the Company in accordance with their respective terms under the laws of the
State of New York.
The opinion stated herein is subject to the following
qualifications:
(i) we
do not express any opinion with respect to the effect on the opinion stated herein of any bankruptcy, insolvency, reorganization, moratorium,
fraudulent transfer, preference and other similar laws or governmental orders affecting creditors’ rights generally, and the opinion
stated herein is limited by such laws and governmental orders and by general principles of equity (regardless of whether enforcement
is sought in equity or at law);
Celestica Inc.
March 3, 2025
Page 3
(ii) we
do not express any opinion with respect to any law, rule or regulation that is applicable to any party to any of the Transaction
Documents or the transactions contemplated thereby solely because such law, rule or regulation is part of a regulatory regime applicable
to any such party or any of its affiliates as a result of the specific assets or business operations of such party or such affiliates;
(iii) except
to the extent expressly stated in the opinion contained herein, we have assumed that each of the Transaction Documents constitutes the
valid and binding obligation of each party to such Transaction Document, enforceable against such party in accordance with its terms;
(iv) we
do not express any opinion with respect to the enforceability of any provision contained in any Transaction Document relating to any
indemnification, contribution, non-reliance, exculpation, release, limitation or exclusion of remedies, waiver or other provisions having
similar effect that may be contrary to public policy or violative of federal or state securities laws, rules or regulations, or
to the extent any such provision purports to, or has the effect of, waiving or altering any statute of limitations;
(v) we
do not express any opinion with respect to the enforceability of any provision of any Transaction Document to the extent that such section
purports to bind the Company to the exclusive jurisdiction of any particular federal court or courts;
(vi) we
call to your attention that irrespective of the agreement of the parties to any Transaction Document, a court may decline to hear a case
on grounds of forum non conveniens or other doctrine limiting the availability of such court as a forum for resolution of disputes; in
addition, we call to your attention that we do not express any opinion with respect to the subject matter jurisdiction of the federal
courts of the United States of America in any action arising out of or relating to any Transaction Document;
(vii) the
opinion stated herein is limited to the agreements and documents specifically identified in the opinion contained herein (the “Specified
Documents”) without regard to any agreement or other document referenced in any such Specified Document (including agreements or
other documents incorporated by reference or attached or annexed thereto) and without regard to any other agreement or document relating
to any such Specified Document that is not a Transaction Document;
(viii) we
have assumed that any agent of service will have accepted appointment as agent to receive service of process and call to your attention
that we do not express any opinion if and to the extent such agent shall resign such appointment. Further, we do not express any opinion
with respect to the irrevocability of the designation of such agent to receive service of process;
(ix) subsequent
to the effectiveness of the Indenture and immediately prior to the issuance of any series Offered Debt Securities, the Indenture has
not been amended, restated, supplemented or otherwise modified in any way that affects or relates to such series of Offered Debt Securities
other than by the applicable Transaction Documents relating to such series of Offered Debt Securities;
(x) this
opinion letter shall be interpreted in accordance with customary practice of United States lawyers who regularly give opinions in transactions
of this type;
(xi) we
have assumed that the choice of New York law to govern any Transaction Documents and that such choice is and will be a valid and legal
provision;
(xii) we
have assumed that the Indenture will be duly authorized, executed and delivered by the trustee in substantially the form reviewed by
us;
(xiii) we
call to your attention that the opinion stated herein is subject to possible judicial action giving effect to governmental actions or
laws of jurisdictions other than those with respect to which we express our opinion;
Celestica Inc.
March 3, 2025
Page 4
(xiv) we
do not express any opinion with respect to the enforceability of any provision contained in any Transaction Document providing for indemnity
by any party thereto against any loss in obtaining the currency due to such party under any Transaction Document from a court judgment
in another currency; and
(xv) to
the extent that any opinion relates to the enforceability of the choice of New York law and choice of New York forum provisions contained
in any Transaction Document, the opinion stated herein is subject to the qualification that such enforceability may be subject to, in
each case, (i) the exceptions and limitations in New York General Obligations Law sections 5-1401 and 5-1402 and (ii) principles
of comity and constitutionality.
In addition, in rendering the foregoing opinion
we have also assumed that:
(a) the
Company (i) is duly incorporated and is validly existing and in good standing, (ii) has requisite legal status and legal capacity
under the laws of the jurisdiction of its organization and (iii) has complied and will comply with all aspects of the laws of the
jurisdiction of its organization in connection with the transactions contemplated by, and the performance of its obligations under, the
Transaction Documents;
(b) the
Company has the corporate power and authority to execute, deliver and perform all its obligations under each of the Transaction Documents;
(c) neither
the execution and delivery by the Company of the Transaction Documents nor the performance by the Company of its obligations thereunder,
including the issuance and sale of the applicable Debt Securities: (i) conflicts or will conflict with the articles of incorporation
and bylaws of the Company, (ii) constitutes or will constitute a violation of, or a default under, any lease, indenture, agreement
or other instrument to which the Company or its property is subject, (iii) contravened or will contravene any order or decree of
any governmental authority to which the Company or its property is subject, or (iv) violates or will violate any law, rule or
regulation to which the Company or its property is subject (except that we do not make the assumption set forth in this clause (iv) with
respect to the Opined-on Law); and
(d) neither
the execution and delivery by the Company of the Transaction Documents nor the performance by the Company of its obligations thereunder,
including the issuance and sale of the applicable Debt Securities, requires or will require the consent, approval, licensing or authorization
of, or any filing, recording or registration with, any governmental authority under any law, rule or regulation of any jurisdiction.
We hereby consent to the reference to our firm under
the heading “Legal Matters” in the prospectus forming part of the Registration Statement. We also hereby consent to the filing
of this opinion with the Commission as an exhibit to the Registration Statement. In giving this consent, we do not thereby admit that
we are within the category of persons whose consent is required under Section 7 of the Securities Act or the Rules and Regulations.
This opinion is expressed as of the date hereof unless otherwise expressly stated, and we disclaim any undertaking to advise you of any
subsequent changes in the facts stated or assumed herein or of any subsequent changes in applicable laws.
| |
Very truly yours, |
| |
|
| |
/s/ Skadden, Arps, Slate, Meagher & Flom
LLP |
RJD
Exhibit 23.1
Consent of Independent Registered Public Accounting
Firm
The Board of Directors
Celestica Inc.:
We consent to the use of our report dated
February 28, 2025, on the consolidated financial statements of Celestica Inc. (the “Company”), which comprise the consolidated
balance sheets as of December 31, 2024 and 2023, the related consolidated statements of operations, comprehensive income, changes
in equity and cash flows for each of the years in the three-year period ended December 31, 2024, and the related notes, and
our report dated February 28, 2025 on the effectiveness of the Company’s internal control over financial reporting as of December 31,
2024, which are incorporated by reference, and to the reference to our firm under the heading “Experts” in the prospectus
included in the Registration Statement on Form S-3 dated March 3, 2025 of the Company.
/s/ KPMG LLP
Chartered Professional Accountants, Licensed Public Accountants
March 3, 2025
Toronto, Canada
S-3
S-3ASR
EX-FILING FEES
0001030894
CELESTICA INC
0001030894
2025-03-03
2025-03-03
0001030894
1
2025-03-03
2025-03-03
0001030894
2
2025-03-03
2025-03-03
0001030894
3
2025-03-03
2025-03-03
0001030894
4
2025-03-03
2025-03-03
0001030894
5
2025-03-03
2025-03-03
0001030894
6
2025-03-03
2025-03-03
0001030894
7
2025-03-03
2025-03-03
0001030894
8
2025-03-03
2025-03-03
iso4217:USD
xbrli:pure
xbrli:shares
|
Calculation of Filing Fee Tables
|
|
S-3
|
|
CELESTICA INC
|
|
Table 1: Newly Registered and Carry Forward Securities
|
|
|
|
Security Type
|
Security Class Title
|
Fee Calculation or Carry Forward Rule
|
Amount Registered
|
Proposed Maximum Offering Price Per Unit
|
Maximum Aggregate Offering Price
|
Fee Rate
|
Amount of Registration Fee
|
Carry Forward Form Type
|
Carry Forward File Number
|
Carry Forward Initial Effective Date
|
Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward
|
|
Newly Registered Securities
|
|
Fees to be Paid
|
1
|
Equity
|
Common shares, without par value
|
457(r)
|
|
|
|
0.0001531
|
|
|
|
|
|
|
Fees to be Paid
|
2
|
Equity
|
Preferred shares, without par value
|
457(r)
|
|
|
|
0.0001531
|
|
|
|
|
|
|
Fees to be Paid
|
3
|
Debt
|
Debt securities
|
457(r)
|
|
|
|
0.0001531
|
|
|
|
|
|
|
Fees to be Paid
|
4
|
Other
|
Warrants to purchase common shares, preferred shares, debt securities or other securities
|
457(r)
|
|
|
|
0.0001531
|
|
|
|
|
|
|
Fees Previously Paid
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Carry Forward Securities
|
|
Carry Forward Securities
|
5
|
Equity
|
Common shares, without par value
|
415(a)(6)
|
|
|
$
643,337,715.93
|
|
|
F-3
|
333-273467
|
07/27/2023
|
$
162,027.76
|
|
Carry Forward Securities
|
6
|
Equity
|
Preferred shares, without par value
|
415(a)(6)
|
|
|
$
643,337,715.93
|
|
|
F-3
|
333-273467
|
07/27/2023
|
$
162,027.76
|
|
Carry Forward Securities
|
7
|
Debt
|
Debt securities
|
415(a)(6)
|
|
|
$
643,337,715.93
|
|
|
F-3
|
333-273467
|
07/27/2023
|
$
162,027.76
|
|
Carry Forward Securities
|
8
|
Other
|
Warrants to purchase common shares, preferred shares, debt securities or other securities
|
415(a)(6)
|
|
|
$
643,337,715.93
|
|
|
F-3
|
333-273467
|
07/27/2023
|
$
162,027.76
|
|
|
|
|
Total Offering Amounts:
|
|
$
2,573,350,863.72
|
|
$
0.00
|
|
|
|
|
|
|
|
|
Total Fees Previously Paid:
|
|
|
|
$
0.00
|
|
|
|
|
|
|
|
|
Total Fee Offsets:
|
|
|
|
$
0.00
|
|
|
|
|
|
|
|
|
Net Fee Due:
|
|
|
|
$
0.00
|
|
|
|
|
|
1
|
An indeterminate aggregate initial offering price or principal amount or number of securities of each identified class is being registered as may from time to time be offered at indeterminate prices and as may from time to time be issued upon conversion, redemption, exchange, exercise or settlement of any securities registered hereunder, including under any applicable anti-dilution provisions.
In accordance with Rules 456(b) and 457(r) under the Securities Act, the Registrant is deferring payments of all of the registration fees (except with respect to the carry forward securities identified in the "Carry Forward Securities" table above and footnote 5 below, with respect to which registration fees have already been paid). Any subsequent registration fees will be paid on a pay-as-you-go basis based on the fee rate in effect on the date of such fee payment.
|
|
|
|
2
|
See footnote 1.
|
|
|
|
3
|
See footnote 1.
|
|
|
|
4
|
See footnote 1.
|
|
|
|
5
|
Pursuant to Rule 415(a)(6) of the Securities Act, this Registration Statement includes and carries forward $2,573,350,863.72 of unsold common shares, preferred shares, debt securities and warrants to purchase common shares, preferred shares, debt securities or other securities ("Unsold Securities") that were previously registered by the Registrant pursuant to its registration statement on Form F-3 (File No. 333-273467) with the Securities and Exchange Commission on July 27, 2023 (the "2023 Registration Statement"); filing fees of $648,111.04 have already been paid with respect to such unsold securities ("Unutilized Fees"). In accordance with Rule 415(a)(6) of the Securities Act, the Unutilized Fees will continue to be applied to such Unsold Securities and are being carried forward to this Registration Statement. The effectiveness of this Registration Statement will be deemed to terminate the 2023 Registration Statement.
|
|
|
|
6
|
See footnote 5.
|
|
|
|
7
|
See footnote 5.
|
|
|
|
8
|
See footnote 5.
|
|
|
v3.25.0.1
| X |
- DefinitionA unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK. Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
| Name: |
dei_EntityCentralIndexKey |
| Namespace Prefix: |
dei_ |
| Data Type: |
dei:centralIndexKeyItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionThe exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC. Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
| Name: |
dei_EntityRegistrantName |
| Namespace Prefix: |
dei_ |
| Data Type: |
xbrli:normalizedStringItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- References
+ Details
| Name: |
ffd_FeeExhibitTp |
| Namespace Prefix: |
ffd_ |
| Data Type: |
ffd:feeExhibitTypeItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- References
+ Details
| Name: |
ffd_SubmissionLineItems |
| Namespace Prefix: |
ffd_ |
| Data Type: |
xbrli:stringItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- References
+ Details
| Name: |
ffd_SubmissnTp |
| Namespace Prefix: |
ffd_ |
| Data Type: |
ffd:submissionTypeItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
v3.25.0.1
Offerings
|
Mar. 03, 2025
USD ($)
|
| Offering: 1 |
|
| Offering: |
|
| Fee Previously Paid |
false
|
| Rule 457(r) |
true
|
| Security Type |
Equity
|
| Security Class Title |
Common shares, without par value
|
| Fee Rate |
0.01531%
|
| Offering Note |
An indeterminate aggregate initial offering price or principal amount or number of securities of each identified class is being registered as may from time to time be offered at indeterminate prices and as may from time to time be issued upon conversion, redemption, exchange, exercise or settlement of any securities registered hereunder, including under any applicable anti-dilution provisions.
In accordance with Rules 456(b) and 457(r) under the Securities Act, the Registrant is deferring payments of all of the registration fees (except with respect to the carry forward securities identified in the "Carry Forward Securities" table above and footnote 5 below, with respect to which registration fees have already been paid). Any subsequent registration fees will be paid on a pay-as-you-go basis based on the fee rate in effect on the date of such fee payment.
|
| Offering: 2 |
|
| Offering: |
|
| Fee Previously Paid |
false
|
| Rule 457(r) |
true
|
| Security Type |
Equity
|
| Security Class Title |
Preferred shares, without par value
|
| Fee Rate |
0.01531%
|
| Offering Note |
See footnote 1.
|
| Offering: 3 |
|
| Offering: |
|
| Fee Previously Paid |
false
|
| Rule 457(r) |
true
|
| Security Type |
Debt
|
| Security Class Title |
Debt securities
|
| Fee Rate |
0.01531%
|
| Offering Note |
See footnote 1.
|
| Offering: 4 |
|
| Offering: |
|
| Fee Previously Paid |
false
|
| Rule 457(r) |
true
|
| Security Type |
Other
|
| Security Class Title |
Warrants to purchase common shares, preferred shares, debt securities or other securities
|
| Fee Rate |
0.01531%
|
| Offering Note |
See footnote 1.
|
| Offering: 5 |
|
| Offering: |
|
| Rule 415(a)(6) |
true
|
| Security Type |
Equity
|
| Security Class Title |
Common shares, without par value
|
| Maximum Aggregate Offering Price |
$ 643,337,715.93
|
| Carry Forward Form Type |
F-3
|
| Carry Forward File Number |
333-273467
|
| Carry Forward Initial Effective Date |
Jul. 27, 2023
|
| Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward |
$ 162,027.76
|
| Offering Note |
Pursuant to Rule 415(a)(6) of the Securities Act, this Registration Statement includes and carries forward $2,573,350,863.72 of unsold common shares, preferred shares, debt securities and warrants to purchase common shares, preferred shares, debt securities or other securities ("Unsold Securities") that were previously registered by the Registrant pursuant to its registration statement on Form F-3 (File No. 333-273467) with the Securities and Exchange Commission on July 27, 2023 (the "2023 Registration Statement"); filing fees of $648,111.04 have already been paid with respect to such unsold securities ("Unutilized Fees"). In accordance with Rule 415(a)(6) of the Securities Act, the Unutilized Fees will continue to be applied to such Unsold Securities and are being carried forward to this Registration Statement. The effectiveness of this Registration Statement will be deemed to terminate the 2023 Registration Statement.
|
| Offering: 6 |
|
| Offering: |
|
| Rule 415(a)(6) |
true
|
| Security Type |
Equity
|
| Security Class Title |
Preferred shares, without par value
|
| Maximum Aggregate Offering Price |
$ 643,337,715.93
|
| Carry Forward Form Type |
F-3
|
| Carry Forward File Number |
333-273467
|
| Carry Forward Initial Effective Date |
Jul. 27, 2023
|
| Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward |
$ 162,027.76
|
| Offering Note |
See footnote 5.
|
| Offering: 7 |
|
| Offering: |
|
| Rule 415(a)(6) |
true
|
| Security Type |
Debt
|
| Security Class Title |
Debt securities
|
| Maximum Aggregate Offering Price |
$ 643,337,715.93
|
| Carry Forward Form Type |
F-3
|
| Carry Forward File Number |
333-273467
|
| Carry Forward Initial Effective Date |
Jul. 27, 2023
|
| Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward |
$ 162,027.76
|
| Offering Note |
See footnote 5.
|
| Offering: 8 |
|
| Offering: |
|
| Rule 415(a)(6) |
true
|
| Security Type |
Other
|
| Security Class Title |
Warrants to purchase common shares, preferred shares, debt securities or other securities
|
| Maximum Aggregate Offering Price |
$ 643,337,715.93
|
| Carry Forward Form Type |
F-3
|
| Carry Forward File Number |
333-273467
|
| Carry Forward Initial Effective Date |
Jul. 27, 2023
|
| Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward |
$ 162,027.76
|
| Offering Note |
See footnote 5.
|
| X |
- DefinitionThe fee previously paid in connection with the securities being brought forward from the prior shelf registration statement on which unsold securities are carried forward under 415(a)(6). Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Securities Act
-Number 230
-Section 415
-Subsection a
| Name: |
ffd_CfwdPrevslyPdFee |
| Namespace Prefix: |
ffd_ |
| Data Type: |
ffd:nonNegative1TMonetary2ItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionThe initial effective date of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Securities Act
-Number 230
-Section 415
-Subsection a
| Name: |
ffd_CfwdPrrFctvDt |
| Namespace Prefix: |
ffd_ |
| Data Type: |
xbrli:dateItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionThe EDGAR File Number of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). If the prior registration statement has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used. Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Securities Act
-Number 230
-Section 415
-Subsection a
| Name: |
ffd_CfwdPrrFileNb |
| Namespace Prefix: |
ffd_ |
| Data Type: |
ffd:fileNumberItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionThe rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission. Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Securities Act
-Number 230
| Name: |
ffd_FeeRate |
| Namespace Prefix: |
ffd_ |
| Data Type: |
dtr-types:percentItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionThe maximum aggregate offering price for the offering that is being registered. Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Securities Act
-Number 230
| Name: |
ffd_MaxAggtOfferingPric |
| Namespace Prefix: |
ffd_ |
| Data Type: |
ffd:nonNegative100TMonetary2ItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Securities Act
-Number 230
| Name: |
ffd_OfferingNote |
| Namespace Prefix: |
ffd_ |
| Data Type: |
dtr-types:textBlockItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionThe title of the class of securities being registered (for each class being registered). Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Securities Act
-Number 230
| Name: |
ffd_OfferingSctyTitl |
| Namespace Prefix: |
ffd_ |
| Data Type: |
ffd:securityTitleItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionType of securities: "Asset-backed Securities", "ADRs/ADSs", "Debt", "Debt Convertible into Equity", "Equity", "Face Amount Certificates", "Limited Partnership Interests", "Mortgage Backed Securities", "Non-Convertible Debt", "Unallocated (Universal) Shelf", "Exchange Traded Vehicle Securities", "Other" Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Securities Act
-Number 230
| Name: |
ffd_OfferingSctyTp |
| Namespace Prefix: |
ffd_ |
| Data Type: |
ffd:securityTypeItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- References
+ Details
| Name: |
ffd_OfferingTable |
| Namespace Prefix: |
ffd_ |
| Data Type: |
xbrli:stringItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- References
+ Details
| Name: |
ffd_PrevslyPdFlg |
| Namespace Prefix: |
ffd_ |
| Data Type: |
xbrli:booleanItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionCheckbox indicating whether filer is claiming a 415(a)(6) carryforward. Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Securities Act
-Number 230
-Section 415
-Subsection a
| Name: |
ffd_Rule415a6Flg |
| Namespace Prefix: |
ffd_ |
| Data Type: |
xbrli:booleanItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Securities Act
-Number 230
-Section 457
-Subsection r
| Name: |
ffd_Rule457rFlg |
| Namespace Prefix: |
ffd_ |
| Data Type: |
xbrli:booleanItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- Details
| Name: |
ffd_OfferingAxis=1 |
| Namespace Prefix: |
|
| Data Type: |
na |
| Balance Type: |
|
| Period Type: |
|
|
| X |
- Details
| Name: |
ffd_OfferingAxis=2 |
| Namespace Prefix: |
|
| Data Type: |
na |
| Balance Type: |
|
| Period Type: |
|
|
| X |
- Details
| Name: |
ffd_OfferingAxis=3 |
| Namespace Prefix: |
|
| Data Type: |
na |
| Balance Type: |
|
| Period Type: |
|
|
| X |
- Details
| Name: |
ffd_OfferingAxis=4 |
| Namespace Prefix: |
|
| Data Type: |
na |
| Balance Type: |
|
| Period Type: |
|
|
| X |
- Details
| Name: |
ffd_OfferingAxis=5 |
| Namespace Prefix: |
|
| Data Type: |
na |
| Balance Type: |
|
| Period Type: |
|
|
| X |
- Details
| Name: |
ffd_OfferingAxis=6 |
| Namespace Prefix: |
|
| Data Type: |
na |
| Balance Type: |
|
| Period Type: |
|
|
| X |
- Details
| Name: |
ffd_OfferingAxis=7 |
| Namespace Prefix: |
|
| Data Type: |
na |
| Balance Type: |
|
| Period Type: |
|
|
| X |
- Details
| Name: |
ffd_OfferingAxis=8 |
| Namespace Prefix: |
|
| Data Type: |
na |
| Balance Type: |
|
| Period Type: |
|
|
v3.25.0.1
| X |
- ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Securities Act
-Number 230
| Name: |
ffd_FeesSummaryLineItems |
| Namespace Prefix: |
ffd_ |
| Data Type: |
xbrli:stringItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Securities Act
-Number 230
| Name: |
ffd_NetFeeAmt |
| Namespace Prefix: |
ffd_ |
| Data Type: |
xbrli:monetaryItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Securities Act
-Number 230
| Name: |
ffd_TtlFeeAmt |
| Namespace Prefix: |
ffd_ |
| Data Type: |
ffd:nonNegative1TMonetary2ItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Securities Act
-Number 230
| Name: |
ffd_TtlOfferingAmt |
| Namespace Prefix: |
ffd_ |
| Data Type: |
ffd:nonNegative1TMonetary2ItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Securities Act
-Number 230
| Name: |
ffd_TtlOffsetAmt |
| Namespace Prefix: |
ffd_ |
| Data Type: |
ffd:nonNegative1TMonetary2ItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Securities Act
-Number 230
| Name: |
ffd_TtlPrevslyPdAmt |
| Namespace Prefix: |
ffd_ |
| Data Type: |
ffd:nonNegative1TMonetary2ItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
Grafico Azioni Celestica (NYSE:CLS)
Storico
Da Feb 2025 a Mar 2025
Grafico Azioni Celestica (NYSE:CLS)
Storico
Da Mar 2024 a Mar 2025
